![]() |
![]() |
![]() |
![]() |
PH-0038 | RT and concomitant CDDP vs cetuximab for head and neck cancer: long term outcomes of a randomized PH. II trial | Davide Tomasini | ![]() |
![]() |
|||
PH-0039 | Impact of sarcopenia on survival and recurrence after radiotherapy for head and neck cancer | thureau sebastien | ![]() |
![]() |
|||
PH-0040 | A 6-point scale approach to 18F-FDG PET-CT for response assessment in HNSCC: a multicenter study | Pierluigi Bonomo | ![]() |
![]() |
|||
PH-0041 | Substantial long-term morbidity after radiotherapy for sinonasal cancer. A cross sectional study | Maja Bendtsen Sharma | ![]() |
![]() |
|||
PH-0042 | Aspiration related Organs At Risk (OARs) are relevant predictors of silent aspiration after (chemo)radiation. | Agata Bannink-Gawryszuk | ![]() |
![]() |
|||
PH-0043 | Age related toxicity and outcome in oropharyngeal and nasoparyngeal cancer patients | Nicola Alessandro Iacovelli | ![]() |
![]() |
|||
PH-0044 | Anaplastic thyroid carcinoma in the Netherlands, very bad but not for all | Mischa de Ridder | ![]() |
![]() |
|||
PH-0046 | Characterization of ionization chambers in magnetic fields for MR guided proton beam therapy | Hermann Fuchs | ![]() |
![]() |
|||
PH-0047 | Small-cavity chamber dose response to megavoltage photon beams in the presence of magnetic fields | Yunuen Cervantes Espinosa | ![]() |
![]() |
|||
PH-0048 | Recombination effects on the liquid-filled ionization chamber array used in VMAT quality control | Noelia Solís Preciado | ![]() |
![]() |
|||
PH-0049 | Organic semiconductors photodiodes for ionising radiation dosimetry | Jessie Posar | ![]() |
![]() |
|||
PH-0050 | Results of 2 years of automated pre-treatment and absolute transit in vivo dosimetry. | Evy Bossuyt | ![]() |
![]() |
|||
PD-0051 | The impact of neuroradiology collaboration in head and neck cancer radiotherapy peer review | Rashmi Jadon | ![]() |
![]() |
|||
PD-0052 | Interobserver variability in organ at risk delineation in head and neck cancer | Julie van der Veen | ![]() |
![]() |
|||
PD-0055 | Outcome in patients with isolated regional recurrence after primary radiotherapy for head and neck cancer | Anne Marie Lindegaard | ![]() |
![]() |
|||
PD-0056 | Factors predicting acute and late gastrointestinal and genitourinary toxicity in prostate cancer | Silvia Cammelli | ![]() |
![]() |
|||
PD-0057 | Patient-reported outcomes after prostate only vs prostate and pelvic lymph node radiation therapy. | Matthew Parry | ![]() |
![]() |
|||
PD-0058 | Adjusting the Duration of Androgen Deprivation Therapy (ADT) based on Nadir PSA in High Risk Localized Prostate Cancer Patients Treated with Definitive External Beam Radiation Therapy and ADT | Zeina Ayoub | ![]() |
![]() |
|||
PD-0059 | Patient-reported baseline incontinence at post-prostatectomy RT: its dependence on time from surgery | Claudio Fiorino | ![]() |
![]() |
|||
PD-0060 | Treatment-related toxicity of hypofractionated radiation therapy for prostate cancer | Matthew Parry | ![]() |
![]() |
|||
PD-0061 | Does the dose to penile bulb/internal pudendal arteries matter for erectile dysfunction post-SBRT? | Giorgio Lamanna | ![]() |
![]() |
|||
PD-0062 | Clinical modulation of tumour immune infiltrates and plasma cytokines by ATR inhibition radiation | Magnus Dillon | ![]() |
![]() |
|||
PD-0063 | SIRT2 prevents cisplatin-induced peripheral neuron injury by enhancing nucleotide excision repair | Scarlett Acklin | ![]() |
![]() |
|||
PD-0065 | Utilizing a high-throughput approach to identify effective agents for aggressive thyroid cancer | Abdallah S. R. Mohamed | ![]() |
![]() |
|||
PD-0067 | An ex vivo assay to detect radiosensitization by PARP-inhibitors in soft tissue sarcomas | Monica Mangoni | ![]() |
![]() |
|||
PD-0068 | Streamlining the image-guided radiotherapy process for proton beam therapy: a service evaluation | Lucy Davies | ![]() |
![]() |
|||
PD-0069 | Use of prescription isodose boundary to optimise treatment delivery during MR-guided Radiotherapy | Claudio Votta | ![]() |
![]() |
|||
PD-0070 | Contour propagation for online treatment of rectal cancer using MR guidance | Ayodeji Adams | ![]() |
![]() |
|||
PD-0071 | The MR-Linac put into practice: 1.5 years of clinical experience of MRgRT | Sophie de Mol van Otterloo | ![]() |
![]() |
|||
PD-0072 | Evaluation of intra thoracic anatomical changes based on the lung traffic light protocol | Filipa Sousa | ![]() |
![]() |
|||
PD-0073 | Outcomes in patients aged 70 and above treated with radical radiotherapy for head and neck cancer | Lisa Hay | ![]() |
![]() |
|||
PH-0114 | Anorectal dose-effect relations for late gastrointestinal toxicity following external beam radiotherapy for prostate cancer in the FLAME trial | Veerle Groen | ![]() |
![]() |
|||
PH-0115 | Five-year outcomes of 51.6 Gy (RBE) in 12-fractionated carbon-ion RT for localized prostate cancer | Hiraku Sato | ![]() |
![]() |
|||
PH-0116 | Stereotactic radiotherapy for prostate cancer: preliminary results of a phase II prospective trial | Paul Nguyen | ![]() |
![]() |
|||
PH-0117 | Radiotherapy of T4M0 prostate cancer : A multicentric retrospective analysis | Flora Goupy | ![]() |
![]() |
|||
PH-0118 | Stereotactic or conventional RT for macroscopic prostate bed recurrence: a propensity score analysis | Lucia Pia Ciccone | ![]() |
![]() |
|||
PH-0119 | Modulations of gut microbiota following radiotherapy for prostate cancer | Eliana Gioscio | ![]() |
![]() |
|||
PH-0120 | The influence of telomere length on mortality in prostate cancer patients treated with radiotherapy. | Katarzyna Lukasiak | ![]() |
![]() |
|||
PH-0121 | Selecting the optimal fiducial marker to reduce the PTV margins for partial breast irradiation | Nienke Hoekstra | ![]() |
![]() |
|||
PH-0123 | DIR based dose accumulation to validate reduced PTV and PRV margins in head-and-neck radiotherapy | Nicholas Lowther | ![]() |
![]() |
|||
PH-0124 | Dosimetric effect of intrafraction motion for different correction strategies in prostate SBRT | Antti Vanhanen | ![]() |
![]() |
|||
PH-0126 | Online 3D prostate cine-MRI on the MR-linac: dosimetric impact of intrafraction motion | Charis Kontaxis | ![]() |
![]() |
|||
PH-0127 | Quantifying intra-fractional gastric wall motion for MR-guided radiotherapy | Theo Driever | ![]() |
![]() |
|||
PH-0156 | Pattern of care and outcomes in stage III esophageal cancer receiving definitive chemoradiation | Ying-Hsiang Chou | ![]() |
![]() |
|||
PH-0158 | The role of adjuvant radiation therapy in non-hilar extrahepatic bile duct cancer | Won Ick Chang | ![]() |
![]() |
|||
PH-0159 | NANORAY-103: Phase I/II trial of NBTXR3 activated by SBRT in patients with HCC and liver metastases | Thierry De Baère | ![]() |
![]() |
|||
PH-0160 | Update of a mono-institutional, retrospective cohort of patients with a diagnosis of primary or recurrent hepatocellular carcinoma treated with stereotactic body radiation therapy: tumor control, survival and toxicity | Jacopo Di Muzio | ![]() |
![]() |
|||
PH-0161 | Elective clinical target volumes for rectal IMRT delivery moving towards a UK wide consensus | Sean OCathail | ![]() |
![]() |
|||
PH-0162 | Is there a radiation dose-response relationship for non-operative management of rectal cancer? | Ane Appelt | ![]() |
![]() |
|||
PH-0163 | Harmonization of breast cancer radiotherapy treatment planning in the Netherlands | Koen Crama | ![]() |
![]() |
|||
PH-0164 | A randomised clinical feasibility trial of a breast immobilisation device:The SuPPORT 4 All Project. | Heidi Probst | ![]() |
![]() |
|||
PH-0166 | Bilateral breast treatment comparative: mono and bi-isocentric VMAT treatment plan. | Anna Coral | ![]() |
![]() |
|||
PH-0167 | Dosimetric stability of left breast cancer irradiation in DIBH triggered with RPM | Sonia Bermejo | ![]() |
![]() |
|||
PH-0168 | Can the use of PET/MR improve target delineation accuracy in RT planning for H&N cancer patients? | York Sze Wong | ![]() |
![]() |
|||
PH-0169 | Dosimetric comparison of IMRT and IMPT in the treatment of recurrent nasopharyngeal carcinoma | Hing Ming Hung | ![]() |
![]() |
|||
PD-0170 | Volumetric regression in brain metastases after stereotactic RT: Time course and significance | Florian Putz | ![]() |
![]() |
|||
PD-0174 | Predictive factors for local and distant brain control and survival after SRT of brain metastases | Katarzyna Holub | ![]() |
![]() |
|||
PD-0175 | TTIRS trial:a retrospective analysis of the association between TT or IT and RS for BM from NSCLC | emanuela olmetto | ![]() |
![]() |
|||
PD-0176 | Survival After Breast-Conserving Therapy Compared With Mastectomy in Stage I-IIA Breast Cancer | Ivica Ratosa | ![]() |
![]() |
|||
PD-0177 | Interfraction heart motion during Deep Inspiration Breath Hold (DIBH) radiotherapy measured by daily CBCT. | Sofian Benkhaled | ![]() |
![]() |
|||
PD-0178 | NTCP model development and comparison for brain image changes after IMPT for head and neck cancer. | Grete May Engeseth | ![]() |
![]() |
|||
PD-0179 | Clinical results of partial- and whole breast irradiation in early stage breast cancer | Edwin Blke | ![]() |
![]() |
|||
PD-0180 | Interim Report from the SAVE HEART Study: deep inspiration breath-hold in left-sided breast cancer | Stephan Schnecker | ![]() |
![]() |
|||
PD-0181 | Relationship between low dose to heart substructures and heart damage within SAFE trial (NCT2236806) | Viola Salvestrini | ![]() |
![]() |
|||
PD-0182 | Elastically deformed planning CT improves in vivo dosimetry results for Head and Neck treatments | Marco Esposito | ![]() |
![]() |
|||
PD-0183 | Does the detector resolution influence correlations between complexity metrics and VMAT QA results? | SERENELLA RUSSO | ![]() |
![]() |
|||
PD-0185 | Development of a Monte-Carlo head model for a fast online validation of 1.5 T MR-linac plans | Marcel Nachbar | ![]() |
![]() |
|||
PD-0187 | Converting absorbed dose-to-medium to dose-to-water in heterogeneous media | Alexia Delbaere | ![]() |
![]() |
|||
PD-0189 | Individualized Beam Angle Selection for MR-Linac Treatment of Rectal Cancer Patients | Rik Bijman | ![]() |
![]() |
|||
PD-0190 | Update on yesterdays dose Use of delivery log files to refine the daily proton delivery | Michael Matter | ![]() |
![]() |
|||
PD-0191 | Knowledge-based planning improves plan quality for high-risk prostate cancer with four dose levels | Kristine Fjellanger | ![]() |
![]() |
|||
PD-0192 | Early clinical experience with a total body irradiation technique using field-in-field beams and on-line image guidance | Ruud van Leeuwen | ![]() |
![]() |
|||
PD-0193 | Validation of a multi-centre knowledge-based planning model for radiotherapy of cervical cancer | Liz Adams | ![]() |
![]() |
|||
PH-0232 | Metabolic profiles do not recover to normal after pelvic IMRT for high-risk prostate cancer. | Miguel Reis Ferreira | ![]() |
![]() |
|||
PH-0233 | Microbiome Structures and Function Changes in RE of Cervical Cancer Based on 16S-rDNA Sequencing | Chenying Ma | ![]() |
![]() |
|||
PH-0234 | The Adaptive Resistome in TNBC: Functional Targeting in Patient-derived Organoids and Cell Lines | Sandra Classen | ![]() |
![]() |
|||
PH-0235 | Downregulation of BCL10 attenuates tumor growth and enhances radiosensitivity in pancreatic cancer | Sung-Hsin Kuo | ![]() |
![]() |
|||
PH-0238 | Optimisation of a Prompt-Gamma Slit Imaging System for Particle Beam Range Verification | Anna Vella | ![]() |
![]() |
|||
PH-0239 | Time-resolved dosimetry for validation of 4D dose calculation in PBS proton therapy | Natalia Kostiukhina | ![]() |
![]() |
|||
PH-0240 | An independent platform for dose calculation and log file evaluation in proton therapy | Gabriel Fonseca | ![]() |
![]() |
|||
PH-0241 | A simulator of proton pencil beam scanning delivery | Per Rugaard Poulsen | ![]() |
![]() |
|||
PH-0242 | Maximizing the benefit of limited proton therapy resources through combined proton-photon treatments | Nicolas Loizeau | ![]() |
![]() |
|||
PH-0243 | Joint optimization of combined photon-carbon ion treatments for infiltrative tumors | Amit Ben Antony Bennan | ![]() |
![]() |
|||
PH-0244 | Treatment planning for MRI guided proton therapy: dose calculations in transverse magnetic fields. | Fatima Padilla Cabal | ![]() |
![]() |
|||
PH-0276 | Shared Decision-Making and Decision Support for Prophylactic Cranial Irradiation in SCLC Patients | Anshu Ankolekar | ![]() |
![]() |
|||
PH-0277 | Delineation of whole heart and substructures in thoracic radiotherapy: National guidelines and contouring atlas by the Danish Multidisciplinary Cancer Groups | Marie Louise Milo | ![]() |
![]() |
|||
PH-0278 | Discontinuous schedule stereotactic irradiation increases overall survival in stage I non-small-cell lung carcinoma | Log Duvergé | ![]() |
![]() |
|||
PH-0279 | Accelerated hypofractionated radiotherapy with concurrent chemotherapy for NSCLC: a phase I/II study | Lucyna Kepka | ![]() |
![]() |
|||
PH-0280 | Quality of surgery and RT in stage IIIN2 NSCLC: Insights from the Lung Adjuvant Radiotherapy trial | yasmina moukasse | ![]() |
![]() |
|||
PH-0281 | Outcomes of re-irradiation & repeat radiotherapy in NSCLC: A propensity matched analysis | Lucy Sandhu | ![]() |
![]() |
|||
PH-0282 | Phase 2 Study of Novel Partial Tumor Irradiation for Sparing Peri-Tumoral Immune Microenvironment. | Slavisa Tubin | ![]() |
![]() |
|||
PH-0284 | Dose-effect relation for rib fractures after lung SBRT: Planned vs. delivered dose | Celia Juan-Cruz | ![]() |
![]() |
|||
PH-0285 | NTCP models for severe radiation induced dermatitis after thoracic radiation therapy | Laura Cella | ![]() |
![]() |
|||
PH-0286 | Development of CT-based cardiac model with substructure for dosimetry in late effects studies | Suman Shrestha | ![]() |
![]() |
|||
PH-0287 | Transfer learning and Deep Neural Network for lung and heart dose prediction in breast treatments | Jaime Perez-Alija | ![]() |
![]() |
|||
PH-0288 | Independent external validation of a logistic regression NTCP model for grade 3 oral mucositis | Marjan Sharabiani | ![]() |
![]() |
|||
PH-0289 | Temporary alopecia in photon cranial irradiation: Establishing the dose-response relation using MRI | Astrid van lier | ![]() |
![]() |
|||
PD-0291 | Comparison of 5 different autosegmentation software for left-sided breast cancer patients | Janne Heikkil | ![]() |
![]() |
|||
PD-0293 | The benefit of high hyperthermia dose in re-irradiation of loco-regional recurrent breast cancer. | Akke Bakker | ![]() |
![]() |
|||
PD-0294 | Hypothyroidism in IMRT-VMAT breast cancer supraclavicular radiotherapy : a retrospective study | Grazia Lazzari | ![]() |
![]() |
|||
PD-0295 | FAST approach in early breast cancer irradiation: toxicity and outcome in a 3DCRT vs IMRT comparison | Maria Alessia Zerella | ![]() |
![]() |
|||
PD-0296 | FAPI-PET/CT as a novel diagnostic imaging probe first clinical experience in radiation oncology | Stefan Koerber | ![]() |
![]() |
|||
PD-0297 | Estimating the probability of active tumor in cervical cancer derived from PET/MR-imaging | Sara Pilskog | ![]() |
![]() |
|||
PD-0298 | Long-term characterization of MRI-morphologic alterations after active motion-compensated liver SBRT | Georgia Miebach | ![]() |
![]() |
|||
PD-0299 | Changes in PET/CT uptake between pre/ and post-treatment might predict response in esophageal cancer | Esther Jimenez-Jimenez | ![]() |
![]() |
|||
PD-0301 | Virtual Tangential Arc Therapy (ViTAT): toward large scale auto-planning for breast cancer treatment | Roberta Castriconi | ![]() |
![]() |
|||
PD-0302 | Biological uncertainties in proton therapy for paediatric mediastinal Hodgkin Lymphoma | Marianne Aznar | ![]() |
![]() |
|||
PD-0303 | Plan quality assessment for rectal cancer patients using prediction of organ-at-risk dose metrics | Ana Vaniqui | ![]() |
![]() |
|||
PD-0304 | Treatment plan comparisons between dynamic trajectory radiotherapy and HyperArc | Michael Fix | ![]() |
![]() |
|||
PD-0305 | Comparative planning study between photon SABR & proton beam therapy for the re-irradiation of pelvic cancer recurrence | Eloise Glassborow | ![]() |
![]() |
|||
PD-0306 | Breathing motion robustness of 4D-CT and ITV robust treatment plans in lung cancer IMPT | Oscar Pastor-Serrano | ![]() |
![]() |
|||
PD-0307 | Tumor motion at planning 4D-CT and treatment 4D-CBCT for a large cohort of lung SBRT targets | Tine Bjrn Nielsen | ![]() |
![]() |
|||
PD-0308 | First clinical experience of online adaptive radiotherapy driven by CBCT and artificial intelligence | Patrik Sibolt | ![]() |
![]() |
|||
PD-0309 | Comparison of CBCT based synthetic CT methods for adaptive proton therapy | Adrian Thummerer | ![]() |
![]() |
|||
PD-0310 | CBCT-to-CT synthesis with a single neural network for head-and-neck, lung and breast radiotherapy | Matteo Maspero | ![]() |
![]() |
|||
PD-0311 | Patterns of practice for adaptive and real-time radiation therapy part II: interfractional changes | Jenny Bertholet | ![]() |
![]() |
|||
PD-0312 | Online-adaptive versus robust IMPT for prostate cancer: how much can we gain? | Thyrza Jagt | ![]() |
![]() |
|||
PH-0358 | A score to predict survival of elderly patients newly diagnosed for Glioblastoma | Christoph Straube | ![]() |
![]() |
|||
PH-0359 | Blood plasma based risk stratification of glioblastoma patients | Daniel Fleischmann | ![]() |
![]() |
|||
PH-0360 | Neutrophils and lymphocytes ratio: prognostic marker in glioblastoma | Orit Kaidar-Person | ![]() |
![]() |
|||
PH-0361 | Reactivation of HCMV during RT of the brain results in critical illness and early mortality | Benjamin Frey | ![]() |
![]() |
|||
PH-0363 | Barium-contrasted bone-cements: impact on dosimetry | Scott Crowe | ![]() |
![]() |
|||
PH-0364 | CIED malfunctions during radiotherapy course: a prospective, multi-centre, in-vitro evaluation | Maria Daniela Falco | ![]() |
![]() |
|||
PH-0365 | Can a dual isocentre technique enable cervix treatments on the 1.5T MR-Linac? | Robert Chuter | ![]() |
![]() |
|||
PH-0366 | Predictors of incontinence 2yr after post-prostatectomy RT: evidence of dose & fractionation effects | Andrea Bresolin | ![]() |
![]() |
|||
PH-0368 | Alexithymia, empathy and burn-out amongst medical physicists: the PRO BONO survey | Pierfrancesco Franco | ![]() |
![]() |
|||
PH-0401 | What are the main causes of interfraction motion of the uterine fundus and cervix? | Anthea Cree | ![]() |
![]() |
|||
PH-0403 | Correlation early morbidity with external beam dose volume parameters in loc. advanced cervix cancer | Yvette Seppenwoolde | ![]() |
![]() |
|||
PH-0404 | Risk factors for late diarrhea after radiochemotherapy in cervical cancer: results from the EMBRACE I study | Nina Boje Kibsgaard Jensen | ![]() |
![]() |
|||
PH-0405 | Updated mono-institutional analysis of 177 vaginal and pelvic recurrences of endometrial cancer | Valeria Chiofalo | ![]() |
![]() |
|||
PH-0406 | An IPEM international survey of MRI use for external beam RT treatment planning | richard speight | ![]() |
![]() |
|||
PH-0407 | Tumour-site specific geometric distortions in high field MR-Linac treatments | Signe Winther Hasler | ![]() |
![]() |
|||
PH-0408 | Assessment of the generalizability to pediatric protontherapy of a 3D network generating pseudo-CT | Emilie Alvarez Andres | ![]() |
![]() |
|||
PH-0409 | Development of Phantom materials with independently adjustable MR- and CT-contrast | Alina Elter | ![]() |
![]() |
|||
PH-0410 | Multi-centre, deep learning, synthetic-CT generation for ano-rectal cancer MR-only planning with AI AutoConfidence assessment | David Bird | ![]() |
![]() |
|||
PH-0411 | Neural network based MR-only treatment planning for cervix cancer using low field MR images | Martin Buschmann | ![]() |
![]() |
|||
PD-0414 | Correlating dosimetry with the outcomes - A analysis of UKs largest cohort of lung SABR patients. | Animesh Saha | ![]() |
![]() |
|||
PD-0415 | Bronchial stenosis in central lung tumors treated with Stereotactic Body Radiation Therapy | Barbara Rijksen | ![]() |
![]() |
|||
PD-0416 | DAILY ADAPTIVE STRATEGY SIMULATION IN LUNG CANCER PTS TREATED WITH RTCHT WITH REDUCED CTV-PTV MARGIN | Marco Lorenzo Bonù | ![]() |
![]() |
|||
PD-0417 | The evolution of radiation-induced lung damage following dose-escalated chemo-radiotherapy | Edward Chandy | ![]() |
![]() |
|||
PD-0418 | Dose on cardiac (sub)structures as predictor for OS in early stage NSCLC patients treated with SBRT | Marloes Duijm | ![]() |
![]() |
|||
PD-0419 | Thoracic radiotherapy decreases right ventricle function: first results of the CLARIFY study | E. Slager | ![]() |
![]() |
|||
PD-0420 | Induction by mFOLFIRINOX followed by SIB-SBRT for the neoadjuvant treatment of pancreatic cancer. | Christelle Bouchart | ![]() |
![]() |
|||
PD-0422 | Evaluating inter-observer variation in oesophageal target volume delineation | Owen Nicholas | ![]() |
![]() |
|||
PD-0425 | Radiomics for ion of patients treated with immuno-radiotherapy: pooled analysis from 6 studies | Roger Sun | ![]() |
![]() |
|||
PD-0426 | NTCP model for radiation-induced liver disease: Integration of clinical and dosimetric factors | Anussara Prayongrat | ![]() |
![]() |
|||
PD-0427 | Optimization of preion process in model-based ion for proton in head and neck cancer | Makbule Tambas | ![]() |
![]() |
|||
PD-0428 | Large scale evaluation of sarcopenia as prognostic factor in lung cancer radiotherapy patients | Andrew Green | ![]() |
![]() |
|||
PD-0429 | CT radiomics differentiates levels of radiocurability in tumor subvolumes in head and neck cancer | Marta Bogowicz | ![]() |
![]() |
|||
PD-0430 | Radiation induced dyspnea in lung cancer patients treated with stereotactic body radiation therapy | Laura Cella | ![]() |
![]() |
|||
PD-0431 | Multicentre clinical radiotherapy audit in rectal cancer: results of the IROCA project | Magdalena Fundowicz | ![]() |
![]() |
|||
PD-0432 | Implantable Sensors for Quantifying Tumor Oxygenation | Greg Ekchian | ![]() |
![]() |
|||
PD-0433 | Clinical workflow for treating patients with a metallic hip prosthesis on an MR-linac | Rick Keesman | ![]() |
![]() |
|||
PD-0434 | A Prospective Clinical Evaluation of Mirada DLCExpert Auto-Contouring for Head and Neck OARs. | Chris South | ![]() |
![]() |
|||
PD-0435 | Brainlab ExacTrac Dynamic First pre-clinical validation of surface- and X-Ray positioning accuracy | Vanessa da Silva Mendes | ![]() |
![]() |
|||
PD-0436 | Dose simulations of a novel aluminium-alloy 3D range-modulator for proton therapy | Yuri Simeonov | ![]() |
![]() |
|||
PH-0476 | Impact of single dose photon or 12C-ion irradiation on rat prostate tumors assessed by DCE-MRI | Alina Bendinger | ![]() |
![]() |
|||
PH-0477 | Effectiveness of fractionated carbon ion treatments in three rat prostate tumors | Christin Glowa | ![]() |
![]() |
|||
PH-0479 | The influence of the tissue specific parameter a/ on the RBE of protons | Elisabeth Mara | ![]() |
![]() |
|||
PH-0480 | Early repair mechanisms after Synchrotron Microbeam Radiation Therapy in normal lung tissue | Verdiana Trappetti | ![]() |
![]() |
|||
PH-0481 | Synchrotron Microbeam Radiation Therapy increases the therapeutic index for brain tumor treatment. | Laura Eling | ![]() |
![]() |
|||
PH-0482 | Inter-observer variation of burned-in fiducial marker positions for MR-only prostate radiotherapy | Femke Beeksma | ![]() |
![]() |
|||
PH-0484 | Evaluation of AI based contouring tools in prostate cancer RT | Anni Borkvel | ![]() |
![]() |
|||
PH-0485 | A deep image-to-image network organ segmentation algorithm for radiation treatment planning: principles and clinical evaluation | Sebastian Marschner | ![]() |
![]() |
|||
PH-0486 | DOSIMETRIC COMPARISON OF BONE MARROW SPARING VMAT VS 3DCRT IN LOCALLY ADVANCED RECTAL CANCER | Sze Man Lam | ![]() |
![]() |
|||
PH-0487 | Analysis of treatment times and workflow at a 1.5 T MR Linac | Jessica Boldt | ![]() |
![]() |
|||
PH-0488 | Online correction for geometric fidelity in MR-Linac treatments | Lieke Meijers | ![]() |
![]() |
|||
PH-0522 | Fractionation and early mortality in palliative radiotherapy across the English NHS | Katie Spencer | ![]() |
![]() |
|||
PH-0524 | TEACHH model. Our experience in handling. | cecilia escuin troncho | ![]() |
![]() |
|||
PH-0525 | Radio-immunotherapy versus immunotherapy alone tolerability and adverse events | Maike Trommer | ![]() |
![]() |
|||
PH-0526 | Socioeconomic status does not affect survival in patients with brain metastases | Steven Nagtegaal | ![]() |
![]() |
|||
PH-0527 | The design of an MRI/PET for radiotherapy treatment simulation. The search for small tumour volumes | Casper Beijst | ![]() |
![]() |
|||
PH-0528 | Feasibility of MR-guided stereotactic body radiotherapy in 5, 2 or 1 fractions for prostate cancer | Jonathan Mohajer | ![]() |
![]() |
|||
PH-0529 | Prostate intrafraction motion during the preparation and delivery of MR-guided radiotherapy sessions on a 1.5T MR-Linac | Daan de Muinck Keizer | ![]() |
![]() |
|||
PH-0531 | Audit feasibility for geometric distortion of MRI scanners used for Radiotherapy | Meshal Alzahrani | ![]() |
![]() |
|||
PH-0532 | Standardization of brain MRI across machines and protocols: bridging the gap for MRI-based radiomics | Alexandre CARRE | ![]() |
![]() |
|||
PD-0534 | Dose-escalation phase III trial of preoperative chemoradiotherapy in rectal cancer. First results | Fernando López Campos | ![]() |
![]() |
|||
PD-0536 | Bone-marrow sparing IMRT for anal cancer patients: a prospective phase II trial | FRANCESCA ARCADIPANE | ![]() |
![]() |
|||
PD-0537 | Factors Affecting Overall Survival in Non-Metastatic Rectal Cancer: An NCDB analysis | Parvez Shaikh | ![]() |
![]() |
|||
PD-0538 | Rectal cancer: world-wide use of radiotherapy and the importance of more strict lymph node staging | Klara Hammarstrm | ![]() |
![]() |
|||
PD-0539 | CHEMO-MODULATION OF RECTAL CANCER PATHOLOGICAL RESPONSE: PREDICTION OF AN EARLY REGRESSION INDEX | Broggi Sara | ![]() |
![]() |
|||
PD-0541 | Transfer learning for automatic sarcopenia evaluation at T12 vertebral level | Donal McSweeney | ![]() |
![]() |
|||
PD-0544 | Validation of a multi-endpoint risk model for clinical outcome in head-and-neck cancer | Katrin Hkansson | ![]() |
![]() |
|||
PD-0545 | Validation of a predictive model for salivary dysfunction during chemo-IMRT for head-neck cancer | Anna Cavallo | ![]() |
![]() |
|||
PD-0546 | Ten years critical re-evaluation of a Failure mode effect analysis in a radiotherapy department | Pietro Mancosu | ![]() |
![]() |
|||
PD-0548 | Quantitative Analysis of SCOPE 2 Trial 4DCT pre-accrual benchmark cases | jennifer kahan | ![]() |
![]() |
|||
PD-0549 | Improving radiotherapy accuracy with EPID in-vivo dosimetry: results from a multicentric study. | Marco Esposito | ![]() |
![]() |
|||
PD-0552 | Validation of an average anatomy model based on deformable image registration for lung cancer | Gordon Lim | ![]() |
![]() |
|||
PD-0553 | Efficient adaptive RT using CBCT-based dose recalculation for head and neck cancer patients | Geert Wortel | ![]() |
![]() |
|||
PD-0554 | CTV-to-PTV margin assessment for esophageal cancer radiotherapy based on accumulated dose analysis | Mick Boekhoff | ![]() |
![]() |
|||
PD-0555 | Dose-Dependent Splenic Volume Changes during Adrenal Adaptive Stereotactic Ablative Radiotherapy | Hanbo Chen | ![]() |
![]() |
|||
PD-0556 | Using multiple planning scans to predict organ shape variability during RT for prostate cancer | Katarína Furmanová | ![]() |
![]() |
|||
PD-0557 | Biomechanical quality assurance criteria for deformable registration in image guided radiotherapy | Cornel Zachiu | ![]() |
![]() |
|||
PH-0595 | Cardiovascular sequelae after adjuvant therapy in a 10-year cohort of breast cancer patients. | Zihan Li | ![]() |
![]() |
|||
PH-0596 | Whole breast irradiation in comparison to endocrine therapy in early stage breast cancer | Edwin Blke | ![]() |
![]() |
|||
PH-0597 | Radiation and/or endocrine therapy? Recurrence outcomes in low-risk breast cancer patients over 70 | Hannah Dahn | ![]() |
![]() |
|||
PH-0598 | Normo versus hypofractionated whole breast irradiation: Are real life data what we expect? | Sofia Rivera | ![]() |
![]() |
|||
PH-0599 | Body image after breast cancer treatment and determinants associated with impaired body image | Marilot Batenburg | ![]() |
![]() |
|||
PH-0600 | Distribution patterns of lymphatic metastases: influence of axillary lymph node dissection | Christina Schleibinger | ![]() |
![]() |
|||
PH-0602 | Dosimetric impact of central OAR review on rectal and bladder constraint attainment in PACE-B trial | Douglas Brand | ![]() |
![]() |
|||
PH-0603 | Deep learning delineation of GTV for head and neck cancer with multi-modality imaging | Jintao Ren | ![]() |
![]() |
|||
PH-0605 | External validation of deep learning-based contouring of head and neck organs at risk | Ellen Brunenberg | ![]() |
![]() |
|||
PH-0606 | AutoConfidence: Per-patient validation for clinical confidence in deep learning for radiotherapy | Mike Nix | ![]() |
![]() |
|||
PH-0607 | Investigating the potential of deep learning for quality assurance of organ-at-risk contours | Ward van Rooij | ![]() |
![]() |
|||
PH-0608 | Identifying systematic edits in the clinical use of Deep Learning Contours | Mark Gooding | ![]() |
![]() |
|||
PH-0647 | The effect of contouring variation on biochemical recurrence following prostate radiotherapy | Eliana M Vasquez Osorio | ![]() |
![]() |
|||
PH-0648 | Radiotherapy of prostate cancer:impact of treatment characteristics on the incidence of second tumor | Silvia Cammelli | ![]() |
![]() |
|||
PH-0649 | Can we dose escalate in anal cancer without an increase in dose to OARs? | Natalie Abbott | ![]() |
![]() |
|||
PH-0650 | External validation of survival of lung cancer patients due to setup uncertainties towards the heart | Carsten Brink | ![]() |
![]() |
|||
PH-0651 | Validating a hidden Markov model for lung anatomical change classification using EPID dosimetry | Cecile Wolfs | ![]() |
![]() |
|||
PH-0652 | Reliability and prognostic value of radiomic features are highly dependent on choice of feature extraction platform | Isabella Fornacon-Wood | ![]() |
![]() |
|||
PH-0653 | Sacrum D30 38.8Gy3 predicts for insufficiency fracture following pelvic chemo-radiotherapy | Romaana Mir | ![]() |
![]() |
|||
PD-0654 | The Correlation Between Linoleic Acid Metabolic Pathway and Nutritional Risk of Radiation Enteritis | Chenying Ma | ![]() |
![]() |
|||
PD-0656 | A contouring atlas on MRI of emerging pelvic female organs at risk for daily practice radiotherapy | Fabiola Patani | ![]() |
![]() |
|||
PD-0657 | Survival in optimally resected stage III endometrial cancer: adjuvant radiotherapy in the modern era | Jenny Ling-Yu Chen | ![]() |
![]() |
|||
PD-0658 | Suboptimal dosimetric coverage of PET/CT hotspots is associated with recurrence for cervical cancer | Franois Lucia | ![]() |
![]() |
|||
PD-0660 | Radical chemoradiation with IMRT-SIB for LAHNSCC: Preliminary outcome. | Trinanjan Basu | ![]() |
![]() |
|||
PD-0661 | Retropharyngeal Lymphadenopathy in Oropharyngeal Cancers:impact on distant metastasis and survival | Zsuzsanna Iyizoba-Ebozue | ![]() |
![]() |
|||
PD-0662 | Can PNI and BMI predict severe radiation induced toxicities in Head and Neck cancer? | Giuseppe Fanetti | ![]() |
![]() |
|||
PD-0663 | The trend of neutrophil-to-lymphocyte ratio as a predictor of prognosis to nasopharyngeal carcinoma | Pei Yang | ![]() |
![]() |
|||
PD-0665 | Outcomes of head & neck paragangliomas treated with surgery, radiation therapy or close observation. | Akshay Mangaj | ![]() |
![]() |
|||
PD-0666 | Prostate radiotherapy with Carbogen and Nicotinamide. Final results of the phase 1b/II PROCON trial | Kent Yip | ![]() |
![]() |
|||
PD-0667 | Early analysis from two phase I trials on SBRT of isolated nodal recurrences in prostate patients | Francesco Deodato | ![]() |
![]() |
|||
PD-0668 | Longitudinal analysis of patient-reported urinary incontinence 2yr after post-prostatectomy RT | Cesare Cozzarini | ![]() |
![]() |
|||
PD-0670 | Population outcomes of EBRT with LDR brachytherapy boost for intermediate, high-risk prostate cancer | Justin Oh | ![]() |
![]() |
|||
PD-0671 | Matched pair analysis of salvage radiotherapy vs observation for post-prostatectomy PSA recurrence | Thomas Wiegel | ![]() |
![]() |
|||
PD-0672 | Impact of a vacuum cushion on intrafraction motion during online adaptive MR-guided SBRT | Anita Werensteijn-Honingh | ![]() |
![]() |
|||
PD-0674 | The role of radiation therapists in the area of online and adaptive treatment on the MR Linac | Eline De Groot - Van Breugel | ![]() |
![]() |
|||
PD-0675 | Evaluation of transbronchial implanted fiducials for lung tumor tracking in Cyberknife | Yuen Yan Chan | ![]() |
![]() |
|||
PD-0676 | A pilot study on evaluating the breast reproducibility of Chabner XRT Radiation Bra using MRI | Sin Ting Chiu | ![]() |
![]() |
|||
PD-0677 | Breath-hold versus free breathing in SBRT of adrenal metastases | Mirjam Mast | ![]() |
![]() |
|||
PH-0715 | External validation of ERITCP as response predictor in rectal cancer using MR-guided Radiotherapy | Davide Cusumano | ![]() |
![]() |
|||
PH-0716 | Radiomics pCR predictive model in rectal cancer: an intercontinental validation on real world data | JINYI LANG | ![]() |
![]() |
|||
PH-0717 | Locally Advanced Pancreatic Cancer: Robust Radiomic based model of outcome after radio-chemotherapy | Martina Mori | ![]() |
![]() |
|||
PH-0718 | Quantitative MRI in prognosticating clinical outcomes in carcinoma cervix treated with Radiotherapy | Swarupa Mitra | ![]() |
![]() |
|||
PH-0719 | 18F-FDG-PET/CT parameters as predictors of survival and response to nCRT in esophageal cancer | Lisa Marr | ![]() |
![]() |
|||
PH-0721 | Predicting overall survival in central NSCLC treated with SBRT: nomogram development and validation | Marloes Duijm | ![]() |
![]() |
|||
PO-0786 | Comparison of the intra-arterial and systemic chemoradiotherapy for gingival carcinoma | Yuki Mukai | ![]() |
![]() |
|||
PO-0789 | Radiation dose guided surgery for mandibular osteoradionecrosis | Nick West | ![]() |
![]() |
|||
PO-0790 | Single-fraction adjuvant electronic brachytherapy (e-BT) after resection of conjunctival carcinoma | Gustavo Sarria | ![]() |
![]() |
|||
PO-0792 | Reproducibility of the Mixing Ability Test in patients with head and neck cancer | Jorine Vermaire | ![]() |
![]() |
|||
PO-0793 | Does delivered OAR dose improve prediction of late toxicity in head & neck cancer patients? | David Noble | ![]() |
![]() |
|||
PO-0794 | Induction chemotherapy followed by moderately accelerated IMRT in head and neck cancer patients | ALESSIA RE | ![]() |
![]() |
|||
PO-0795 | Pre-chemoradiotherapy nutritional status affects treatment response and survival in HNSCC patients | Yih Mei Liou | ![]() |
![]() |
|||
PO-0796 | Observational study of radiotherapy plus cetuximab in patients with LA-SCCHN: JROSG12-2 | Yosuke Ota | ![]() |
![]() |
|||
PO-0798 | Early Mortality after Radical Radiotherapy in Head and Neck Cancer a Nationwide Analysis from the Danish Head and Neck Cancer Group (DAHANCA) Database | Kristian Hastoft Jensen | ![]() |
![]() |
|||
PO-0799 | Target delineation uncertainties using MRI for H&N cancer patients | Ruta Zukauskaite | ![]() |
![]() |
|||
PO-0802 | Impact of LINE-1 methylation on survival in patients with locally advanced oropharyngeal carcinoma. | Giuseppe Fanetti | ![]() |
![]() |
|||
PO-0804 | Adjuvant radiotherapy in the management of major salivary gland tumors Retrospective analysis | André Florindo | ![]() |
![]() |
|||
PO-0805 | Dental insurance status influences prophylactic dental care prior to head and neck radiation | Andrew Hope | ![]() |
![]() |
|||
PO-0806 | Prognostic value of eosinophil levels in oropharyngeal cancer: a retrospective multicentric study | Francesco Olivero | ![]() |
![]() |
|||
PO-0807 | The association between mean platelet volume and prognosis in patients with oropharyngeal cancer. | Katarzyna Lukasiak | ![]() |
![]() |
|||
PO-0809 | Lymph flow guided radiotherapy for oral tongue cancer: histological verification of the concept | Sergey Novikov | ![]() |
![]() |
|||
PO-0810 | Prognostic value of lymph node-to-primary tumor standardized uptake value ratio in NPC | Tsung-Min Hung | ![]() |
![]() |
|||
PO-0811 | Influence of time between surgery and postoperative radiation therapy in head and neck cancer | Gustavo Marta | ![]() |
![]() |
|||
PO-0812 | Hypofractionated Chemoradiation in LAHNC; QOL, Toxicity and Local Control in Radiation courses. | Gustavo Ferraris | ![]() |
![]() |
|||
PO-0813 | Total tumor volume as a prognostic factor in head and neck cancer patients. | Irfan Bashir | ![]() |
![]() |
|||
PO-0815 | Validation of a Prognostic Model for Predicting Larynx Preservation Outcome in Catalan Population. | Jordi Marruecos Querol | ![]() |
![]() |
|||
PO-0817 | Implication of BRAF mutations in well-differentiated thyroid carcinoma. | Jose Antonio Dominguez Rullán | ![]() |
![]() |
|||
PO-0818 | Feasibility and first experience of MR-guided adaptive radiotherapy for head and neck cancer | Panagiotis Balermpas | ![]() |
![]() |
|||
PO-0819 | Repeated short-course radiotherapy regimen in elderly patients with advanced head and neck cancer | Milena Ferro | ![]() |
![]() |
|||
PO-0820 | Nutritional Risk Index and outcomes for head and neck cancer patients receiving chemo-radiotherapy | Justin Oh | ![]() |
![]() |
|||
PO-0821 | Prognostic Nutritional Index: A Predictive tool of treatment tolerance to head and neck radiotherapy | anu george | ![]() |
![]() |
|||
PO-0822 | Dosimetric predictors of hypothyroidism in nasopharyngeal carcinoma patients treated with IMRT | Yuanyuan Chen | ![]() |
![]() |
|||
PO-0826 | Hypofractionated radiotherapyfor HNSCC: a retrospective analysis of single Institution | Fabrizio Sanna | ![]() |
![]() |
|||
PO-0829 | Osteoradionecrosis of the mandible in head and neck cancer patients treated with VMAT | Carles Munoz Montplet | ![]() |
![]() |
|||
PO-0831 | IMRT for recurrent nasopharyngeal cancer: OAR tolerance and acute toxicity | Aissaoui Dorra | ![]() |
![]() |
|||
PO-0832 | Stereotactic radiotherapy for localized external auditory canal carcinoma | Yoshimasa Mori | ![]() |
![]() |
|||
PO-0834 | Tumor regression during intensity-modulated radiotherapy of nasopharyngeal carcinoma | Daoud Hend | ![]() |
![]() |
|||
PO-0835 | Which are the most tooth bearing areas at risk after IMRT for nasopharyngeal carcinoma ? | Nejla Fourati | ![]() |
![]() |
|||
PO-0836 | ROBOTIC RADIOSURGERY FOR UVEAL MELANOMA: TECHNIQUE AND RESULTS | Sandra Cipkina | ![]() |
![]() |
|||
PO-0837 | Does response to induction chemotherapy predicts prognosis for nasopharyngeal carcinoma? | Omar Nouri | ![]() |
![]() |
|||
PO-0839 | Overlapping Volumes in Re-irradiation for Head and Neck Cancer | Anna Embring | ![]() |
![]() |
|||
PO-0841 | Treatment failure patterns after radical radiotherapy using modern radiation techniques. | André Laranja | ![]() |
![]() |
|||
PO-0842 | PRO.M.E.THE.O.: the development of an italian multicentric OS predictive model in oropharynx cancer | silvia longo | ![]() |
![]() |
|||
PO-0843 | Assessment of weight loss and subjective dysphagia after radiotherapy for head and neck cancer | Marta Maddalo | ![]() |
![]() |
|||
PO-0845 | Role of postoperative RT (PORT) after compartmental surgery for locally advanced oral cavity tumors | Daniela Alterio | ![]() |
![]() |
|||
PO-0846 | Preliminary outcome results of a PET-CT based direct planning protocol in head and neck radiotherapy | Saide Di Biase | ![]() |
![]() |
|||
PO-0847 | Quality of life during chemo-radiotherapy for nasopharyngeal carcinoma: A prospective assessment | Nejla Fourati | ![]() |
![]() |
|||
PO-0850 | PROTON BEAM REIRRADIATION IN HEAD AND NECK PATIENTS AT CNAO: PRELIMINARY RESULTS. | Sara Ronchi | ![]() |
![]() |
|||
PO-0851 | Impact of Adjuvant Radiation Therapy for Advanced Cutaneous Squamous Cell Carcinoma of Head and Neck | Vincent Atallah | ![]() |
![]() |
|||
PO-0852 | Can we ignore Submandibular gland constraints for Xerostomia prevention in Parotid sparing IMRT? | Karishma George | ![]() |
![]() |
|||
PO-0853 | The effect of the smoking cessation for radiation therapy of glottis carcinoma with monitoring CO | Shotaro Tatekawa | ![]() |
![]() |
|||
PO-0854 | Prediction of sensorineural hearing loss in patients undergoing proton therapy for skull base tumors | Nicolaas Roos | ![]() |
![]() |
|||
PO-0855 | Radiation-induced meningiomas: outcomes following stereotactic radiosurgery | Michael Huo | ![]() |
![]() |
|||
PO-0857 | Leptomeningeal disease following stereotactic radiotherapy for resected brain metastases | Susanne Rogers | ![]() |
![]() |
|||
PO-0858 | Stereotactic Radiotherapy for Treatment of Brain Metastases: a monocentric experience | Alessandra Gonnelli | ![]() |
![]() |
|||
PO-0859 | POSTOPERATIVE STEREOTACTIC BRAIN RADIATION THERAPY: A SINGLE CENTRE RETROSPECTIVE ANALYSIS | Silvia Takanen | ![]() |
![]() |
|||
PO-0860 | Hippocampal dose reduction while treating brain gliomas using 3DCRT | Sara Elsharkawy | ![]() |
![]() |
|||
PO-0861 | Survival outcomes after upfront stereotactic radiosurgery for brain metastases from breast cancer | Yan Wang | ![]() |
![]() |
|||
PO-0863 | Radiochemotherapy retreatment in high grade giomas recurrences | Angela Caroli | ![]() |
![]() |
|||
PO-0864 | SRS alone of brain metastases with unfavorable prognostic factors | Maciej Harat | ![]() |
![]() |
|||
PO-0865 | Survival outcomes and prognosis in patients with triple-negative breast cancer and brain metastases | Ran An | ![]() |
![]() |
|||
PO-0866 | The relation between post-radiation injury and postoperative ischemia in diffuse glioma treatment | Arthur van der Boog | ![]() |
![]() |
|||
PO-0869 | Assessment of results of radiosurgery for brain metastases from primary NSCLC cancer | Dorota Jezierska | ![]() |
![]() |
|||
PO-0870 | Impact of GTV on overall survival of Glioblastoma, post definitive therapy: a retrospective study. | Shashank Bansal | ![]() |
![]() |
|||
PO-0871 | Outcomes in Pineal Parenchymal tumours of intermediate differentiation: A single institution study | Aisling Glynn | ![]() |
![]() |
|||
PO-0872 | Craniopharyngiomas treated with Fractionated Stereotactic Radiotherapy (FSR) | Rosario Ching López | ![]() |
![]() |
|||
PO-0873 | Lung Cancer Brain Metastasis: Higher Biologically Effective Dose Radiotherapy may improve survival. | Fatima Aurora Aires | ![]() |
![]() |
|||
PO-0874 | Development of a prognostic model for patients with high-grade meningioma - the ELSA study | Kerstin Kessel | ![]() |
![]() |
|||
PO-0875 | Comparison of risk scores for re-irradiation of patients with recurrent high-grade gliomas (HGG) | Hannah Scholz | ![]() |
![]() |
|||
PO-0876 | Simultaneous stereotactic radiosurgery of multiple brain metastases using single isocenter dynamic conformal arc therapy | Raphael Bodensohn | ![]() |
![]() |
|||
PO-0877 | Hypofractionated and single-fraction SRT for brain metastases with sex as a key predictor of OS | Julian Mangesius | ![]() |
![]() |
|||
PO-0878 | Improving dose distribution by adaptive radiotherapy for glioblastoma: A prospective study | Tomohiko Matsuyama | ![]() |
![]() |
|||
PO-0879 | Stereotactic radiotherapy for re-irradiation of relapsed intracranic lesions | Roberta Tummineri | ![]() |
![]() |
|||
PO-0882 | Single centre review of the survival benefit and toxicity of PCI in Small Cell Lung Cancer | Samantha Forner | ![]() |
![]() |
|||
PO-0883 | Early outcomes in patients with skull base chordomas and chondrosarcomas treated with proton therapy | Ana Turkaj | ![]() |
![]() |
|||
PO-0884 | Risk of radionecrosis in brain metastases treated with SRT and systemic therapy | Katarzyna Holub | ![]() |
![]() |
|||
PO-0885 | Radiation-induced edema in reirradiation of recurrent high-grade gliomas treated with Proton therapy | Ana Turkaj | ![]() |
![]() |
|||
PO-0886 | Leptomeningeal metastases of breast and lung cancer- a retrospective analysis | Indrawati Hadi | ![]() |
![]() |
|||
PO-0889 | Clinical outcome of diffuse midline glioma, H3K27M-mutant treated with post-operative radiotherapy | Kullachart Utaivichakul | ![]() |
![]() |
|||
PO-0891 | Application of radiation therapy to brain metastases with simultaneous or sequential anti-PD-1 treatment: toxicity analysis | Maike Trommer | ![]() |
![]() |
|||
PO-0893 | Radiation therapy in meningioma- single center prospective and retrospective analysis | Indrawati Hadi | ![]() |
![]() |
|||
PO-0894 | Survival in patients with NSCLC with brain metastases treated with WBRT | Filippa Sundbye | ![]() |
![]() |
|||
PO-0895 | GPA in brain metastases treated with Stereotactic Radiosurgery | Maitane Rodriguez | ![]() |
![]() |
|||
PO-0896 | Radionecrosis in brain metastases treated with Stereotactic radiosurgery | Maitane Rodríguez Mendizabal | ![]() |
![]() |
|||
PO-0897 | Dosimetric Consequence of Transient Post-Surgical Anatomical Effects for Glioblastoma | Marcus Tyyger | ![]() |
![]() |
|||
PO-0898 | Primary tumor-status relevance in NSCLC with brain metastases undergoing radiosurgery | Alba Gonzalez Lopez | ![]() |
![]() |
|||
PO-0899 | Risk of brain Radionecrosis after radiosurgery in oligometastatic patients | Ilaria Chiovatero | ![]() |
![]() |
|||
PO-0900 | Radionecrosis in patients with brain metastases treated with stereotactic radiotherapy. | Sandra Fernandez Alonso | ![]() |
![]() |
|||
PO-0901 | Stereotactic radiotherapy in brain metastases. Survival and radiological behavior analysis. | Sandra Fernandez Alonso | ![]() |
![]() |
|||
PO-0903 | CELLULAR PHONEs RADIOFREQUENCY EXPOSURE AND MALIGNANT BRAIN TUMOR:SISTEMATIC REVIEW AND METAANALISYS | Annamaria Guaineri | ![]() |
![]() |
|||
PO-0904 | Irradiated brain volume is not related to the risk of radionecrosis: reconsidering the role of V12Gy | Daniel Versnel | ![]() |
![]() |
|||
PO-0908 | Efficacy and Toxicity of Proton therapy and Tomotherapy combination in sacral chordoma patients | Arnaud Beddok | ![]() |
![]() |
|||
PO-0909 | High-dose carbon-ion based radiotherapy of primary and recurrent sacrococcygeal chordomas | Tilman Bostel | ![]() |
![]() |
|||
PO-0910 | Efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients | Lea Galunic Bilic | ![]() |
![]() |
|||
PO-0912 | Meta-analysis of radiotherapy in salvaging relapse/refractory Diffuse Large B-Cell Lymphoma in the rituximab era | Farasat Kazmi | ![]() |
![]() |
|||
PO-0913 | Effectiveness of radiotherapy for patients with indolent non-Hodgkins lymphoma | Indrawati Hadi | ![]() |
![]() |
|||
PO-0914 | Impact of HIV infection on consolidative radiotherapy for non-Hodgkin diffuse large B-cell lymphoma | Geovanne Pedro Mauro | ![]() |
![]() |
|||
PO-0915 | CLINICAL ACTIVATION OF AN EFFICIENT LOW-DOSE TOTAL BODY IRRADIATION USING THE TOMODIRECT APPROACH | chiara anna | ![]() |
![]() |
|||
PO-0916 | Dose-rate dependence in haematological recovery following total marrow irradiation | André Haraldsson | ![]() |
![]() |
|||
PO-0917 | Radiotherapy-based approach for the treatment of solitary plasmacytoma | Alessandro Alghisi | ![]() |
![]() |
|||
PO-0919 | Low vs intermediate dose radiotherapy in head & neck MALT lymphoma with and without Sjogren syndrome | Charlotte Shelley | ![]() |
![]() |
|||
PO-0920 | Low dose radiation therapy (2 Gy x 2) in the treatment of Marginal Zone Lymphomas | Viola De Luca | ![]() |
![]() |
|||
PO-0922 | De-escalated radiotherapy for indolent primary cutaneous B-cell lymphoma | Michael Oertel | ![]() |
![]() |
|||
PO-0924 | Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin lymphoma | Niklas Benedikt Pepper | ![]() |
![]() |
|||
PO-0925 | Internal Mammary Lymph Node Volumes: What Radiation dose is received with modified wide tangents? | Reem Ujaimi | ![]() |
![]() |
|||
PO-0926 | Derma-QOL after heparinoid moisturizer for radiation damage in breast-conserving surgery patients | Jiro Kawamori | ![]() |
![]() |
|||
PO-0927 | Assessing the Quality of Care in Breast Cancer Radiotherapy | Shalini Vinod | ![]() |
![]() |
|||
PO-0928 | Safety and efficacy of concomitant RT and CDK4/6 inhibitors in metastatic breast cancer patients. | Luca Visani | ![]() |
![]() |
|||
PO-0929 | Mammary chain irradiation: can we reduce the risk of secondary cancer and ischaemic heart disease? | Stefanie Corradini | ![]() |
![]() |
|||
PO-0930 | Wide tangents versus volumetric arc therapy to treat the internal mammary chain using breath hold | Dorothy Gujral | ![]() |
![]() |
|||
PO-0932 | Preoperative radiotherapy for early breast cancer: quality assessment of the ROCK trial -NCT03520894 | Erika Scoccimarro | ![]() |
![]() |
|||
PO-0934 | Nodal outlining based on ESTRO guidelines in breast radiotherapy | Camarie Welgemoed | ![]() |
![]() |
|||
PO-0935 | SAPBI for early stage breast cancer- Feasibility and Early Experiences of a Phase II Clinical Study | Norbert Mészáros | ![]() |
![]() |
|||
PO-0936 | Comparison of local recurrence rates after two different APBI techniques, a prospective study | Daphne Jacobs | ![]() |
![]() |
|||
PO-0937 | Partial breast re-irradiation with IMRT for local recurrence after whole breast radiotherapy | Simona Arculeo | ![]() |
![]() |
|||
PO-0939 | Structured prospective database:exploratory study about toxicity and progression in breast patients. | MARIA LIZONDO | ![]() |
![]() |
|||
PO-0940 | Synchronous bilateral breast cancer irradiation: Clinical-dosimetrical outcomes with VMAT | Jon Gadea | ![]() |
![]() |
|||
PO-0942 | Post-mastectomy radiotherapy after Immediate versus Two-Stage Breast Reconstruction. | Elisabetta Bonzano | ![]() |
![]() |
|||
PO-0943 | Long-term results of hypofractionation with simultaneous integrated boost in early breast cancer. | Kitwadee S. Athigakunagorn | ![]() |
![]() |
|||
PO-0944 | Molecular subtypes in patients with breast cancer that received neoadjuvant chemotherapy | Gustavo Marta | ![]() |
![]() |
|||
PO-0945 | The impact of surgery type in breast cancer patients that received neoadjuvant chemotherapy | Gustavo Marta | ![]() |
![]() |
|||
PO-0946 | Clinical impact of FFF-VMAT combined with DIBH for breast cancer radiotherapy | Darya Mychko | ![]() |
![]() |
|||
PO-0947 | Dosimetric evaluation of organs at risk in APBI patients treated with multicatheter interstitial BT | Marina Maães | ![]() |
![]() |
|||
PO-0948 | Deep inspiration breath-hold for cardioprotection in patients with left-sided breast cancer | Oliver Micke | ![]() |
![]() |
|||
PO-0949 | Maximising patient access to advanced breast radiotherapy techniques and personalised radiotherapy | penny kechagioglou | ![]() |
![]() |
|||
PO-0952 | Hypofractionated WBI in large-breasted patients: long-term toxicity of a prospective series | Fiorenza De Rose | ![]() |
![]() |
|||
PO-0953 | Risk-adapted Postmastectomy Radiotherapy based on Prognostic Nomogram for pT1-2N1M0 Breast Cancer | MING LI | ![]() |
![]() |
|||
PO-0954 | Occult Primary Breast Carcinoma with axillary involvement: two different treatment approaches. | Fausto Sousa | ![]() |
![]() |
|||
PO-0955 | Molecular subtypes and local control in 1054 breast cancer patients treated with de-escalated 3DCRT | Andrei Fodor | ![]() |
![]() |
|||
PO-0956 | Neuroendocrine Tumors of the Breast: an international series of the Rare Cancer Network | Noémie Grellier-Adedjouma | ![]() |
![]() |
|||
PO-0957 | Why does deep inspiration work for radiotherapy of the internal mammary nodes? | Felix Voelk | ![]() |
![]() |
|||
PO-0958 | Neoadjuvant RT followed by mastectomy and immediate breast reconstruction: updated 5-years results | Montserrat Pazos | ![]() |
![]() |
|||
PO-0960 | Metastatic breast cancer Survival impact of locoregional treatment | André Laranja | ![]() |
![]() |
|||
PO-0963 | Impact of regional nodal Irradiation on lung dose in hypofractionated radiation of breast cancer | Meriem Bohli | ![]() |
![]() |
|||
PO-0964 | Reducing radiation dermatitis using a film-forming silicone gel: a pilot randomized controlled trial | KiHoon Sung | ![]() |
![]() |
|||
PO-0966 | Partial breast irradiation at the 1.5T MR-Linac: treatment time and electron stream effect | Chiara De-Colle | ![]() |
![]() |
|||
PO-0967 | Toxicity of concurrent Palbociclib and Radiation therapy in metastatic breast cancer patients | Arnaud Beddok | ![]() |
![]() |
|||
PO-0969 | Stereotactic body radiotherapy in extracranial oligometastatic or oligoprogressive breast cancer | Fabian Weykamp | ![]() |
![]() |
|||
PO-0970 | Tectum11 peptide in prevention and treatment of radiodermatitis in breast cancer | Eva Fernandez Lizarbe | ![]() |
![]() |
|||
PO-0973 | Axillary lymph node dissection after neoadjuvant chemotherapy for node-positive breast cancer. | Marianne van Zeeland | ![]() |
![]() |
|||
PO-0974 | Helical intensity-modulated radiation therapy for locally advanced breast cancer:a prospective study | Benoit Bataille | ![]() |
![]() |
|||
PO-0975 | Retrospective evaluation of clinical outcome and dosimetric aspects in breast cancer reirradiations | Junior Anderson Gomez Ramos | ![]() |
![]() |
|||
PO-0976 | Left sided breast cancer patients and advanced radiotherapy techniques. A cardiac sparing approach. | Francesca Cucciarelli | ![]() |
![]() |
|||
PO-0977 | Hypofractionated external beam radiation therapy for breast cancer: real-life outcomes | Diana Correia | ![]() |
![]() |
|||
PO-0978 | Is there a correlation between radiation doses and heart segmental alterations at 6 months? | Nejla Fourati | ![]() |
![]() |
|||
PO-0979 | Variability of axillary nodal CTV contouring in breast cancer (PART I - geometric evaluation) | Maria Cristina Leonardi | ![]() |
![]() |
|||
PO-0980 | Preliminar evaluation of a new bra for large or pendular breasts irradiation. | Fredy Castaño Zuleta | ![]() |
![]() |
|||
PO-0981 | Variability of axillary nodal CTV contouring in breast cancer (PART II dosimetric impact) | Maria Cristina Leonardi | ![]() |
![]() |
|||
PO-0982 | Preliminary analysis of radiotherapy role on PFS-2 in oligoprogressive breast cancer | Valeria Masiello | ![]() |
![]() |
|||
PO-0985 | Hypofractionated radiotherapy with SIB in advanced incurable breast cancer-HYPORT B study | Ritesh Santosham | ![]() |
![]() |
|||
PO-0986 | Concurrent Chemoradiation for Inoperable Locally Advanced Breast Cancer after Primary Chemotherapy | Bárbara Castro | ![]() |
![]() |
|||
PO-0988 | Is there a learning curve for SABR that affects overall survival outcomes in early stage NSCLC? | Alexander Wood | ![]() |
![]() |
|||
PO-0989 | Radiation therapy for thoracic malignancies: the impact on immune and vascular blood biomarkers | Sonja Adebahr | ![]() |
![]() |
|||
PO-0990 | Prevention of oncologic pulmonary death by control for pulmonary oligometastases treated with SBRT | Takaya Yamamoto | ![]() |
![]() |
|||
PO-0991 | Impact of residual setup errors after image guidance on heart dose in NSCLC patients | Corinne Johnson-Hart | ![]() |
![]() |
|||
PO-0992 | Pericardial effusion after radiotherapy for Non-Small Cell Lung Cancer | Charlotte Linthorst | ![]() |
![]() |
|||
PO-0993 | Multicenter study of stereotactic body radiotherapy in non-small cell lung cancer (KROG 17-09) | Seung Gyu Park | ![]() |
![]() |
|||
PO-0994 | Prognostic factors in elderly patients with lung carcinoma (NSCLC) treated with curative intent | Jon Cacicedo | ![]() |
![]() |
|||
PO-0996 | Early mortality in stage III NSCLC after non-surgical therapy following ESMO guidelines | Ronden Merle | ![]() |
![]() |
|||
PO-0997 | Evaluation of outcome and toxicity of Durvalumab treatment after CRT in inoperable stage III NSCLC | Lukas Ksmann | ![]() |
![]() |
|||
PO-0998 | Durvalumab treatment after CRT in inoperable stage III NSCLC a German radiation oncology survey | Lukas Ksmann | ![]() |
![]() |
|||
PO-0999 | Deciphering the tumor microenviroment based on PD-L1 expression and CD8 TILs density in LA-NSCLC | Lukas Ksmann | ![]() |
![]() |
|||
PO-1000 | Multicentric restrospective analysis of safety of SBRT to centrally located lesion of the lung | luca frassinelli | ![]() |
![]() |
|||
PO-1002 | Early outcomes of stereotactic MR-guided adaptive radiation therapy in 54 high-risk lung tumors | Tobias Finazzi | ![]() |
![]() |
|||
PO-1003 | Preliminary results of SRS for a lung tumor: a single-arm phase 2 study in a single institute | Takaya Yamamoto | ![]() |
![]() |
|||
PO-1004 | Continuous Positive Airway Pressure (CPAP) use for Motion management in Lung SBRT | sarit appel | ![]() |
![]() |
|||
PO-1005 | Influence of PTV underdosage on local control in patients with central NSCLC treated with SBRT | Marloes Duijm | ![]() |
![]() |
|||
PO-1006 | Immunotherapy related pneumonitis correlates with radiomics in NSCLC patients treated with Nivolumab | Ivaylo Mihaylov | ![]() |
![]() |
|||
PO-1007 | Predictors of radiation pneumonitis in early stage lung cancer treated with SABR. | Animesh Saha | ![]() |
![]() |
|||
PO-1008 | Predictive dosimetric parameters of lymphopenia in stage III NSCLC patients with chemoradiation | Ick Joon Cho | ![]() |
![]() |
|||
PO-1010 | Stereotactic Body Radiation Therapy is safe and effective for ultracentral lung lesions | Davide Franceschini | ![]() |
![]() |
|||
PO-1011 | Impact of radiation therapy on immunotherapy efficacy in metastatic non-small cell lung cancer. | Eleonor Rivin del Campo | ![]() |
![]() |
|||
PO-1012 | Prognostic Value of Anemia in Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy | Hotaka Nonaka | ![]() |
![]() |
|||
PO-1013 | A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC. | Cedric Panje | ![]() |
![]() |
|||
PO-1015 | SBRT after CT-RT for stage III unresectable NSCLC with peripheral primary tumor (GFPC 01-14 study) | Isabelle Martel Lafay | ![]() |
![]() |
|||
PO-1018 | Lung SABRT treatment in oligometastatic patients, a prospective review | Emese Csiki | ![]() |
![]() |
|||
PO-1019 | Long term outcomes and lung function evolution of primary lung tumors treated with Cyberknife SABR | Florence Sacino | ![]() |
![]() |
|||
PO-1022 | CLINICAL-DOSIMETRIC ASSESSMENT WITH THE PRODVH SOFTWARE OF PATIENTS TREATED WITH ADJUVANT RADIOTHERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA: A RETROSPECTIVE ANALYSIS | emiliano salah eldin tantawi | ![]() |
![]() |
|||
PO-1023 | Impact of biological features in radiosurgery for Brain metastases from Non Small Cell Lung Cancer | Stefano Durante | ![]() |
![]() |
|||
PO-1024 | Efficacy and safety of fractionated radiotherapy for centrally located early-stage non-small cell lung cancer | Michael Leenders | ![]() |
![]() |
|||
PO-1025 | Prognostic factors for PFS and OS in radically treated patients with oligometastatic NSCLC | Michael Leenders | ![]() |
![]() |
|||
PO-1028 | Consolidation therapy with Durvalumab after radical CRT in stage IIII NSCLC: a preliminar analysis | paolo borghetti | ![]() |
![]() |
|||
PO-1031 | Initial report on feasibility of Hypo-IGRT in stage IIB-III NSCLC pts with poor PS & lung function | Chukwuka Eze | ![]() |
![]() |
|||
PO-1034 | Chemoradiation-induced intratumoral immune microenvironment changes in oesophageal cancer | Connie Yip | ![]() |
![]() |
|||
PO-1036 | Analysis of serum pancreatic exocrine enzyme after radiotherapy for pancreatic carcinoma | Takahiro Iwai | ![]() |
![]() |
|||
PO-1037 | A new nodal delineation protocol for upper third oesophageal cancers in the SCOPE 2 trial | Owen Nicholas | ![]() |
![]() |
|||
PO-1038 | Robotic radiosurgery treatment in HCC with PVT: Interim analysis of a prospective study | Debnarayan Dutta | ![]() |
![]() |
|||
PO-1039 | Lymphopenia and worse OS are associated with GTV and fraction in patients with HCC treated with EBRT | Haige Zhang | ![]() |
![]() |
|||
PO-1041 | Gender disparity in esophageal cancer -- a nationwide propensity score-matched study | Ying-Hsiang Chou | ![]() |
![]() |
|||
PO-1042 | SBRT vs conventionally fractionated radio-chemotherapy for pancreatic cancer: a case-control study | Alessandra Arcellli | ![]() |
![]() |
|||
PO-1043 | Reduction ratio of tumor volume is predictive factor in esophageal carcinoma undergoing chemotherapy | Ruihong Huang | ![]() |
![]() |
|||
PO-1044 | Postoperative hypofractionated Image-Guided IMRT concomitant to chemotherapy in biliary tract cancer | Najla Slim | ![]() |
![]() |
|||
PO-1047 | GemOx with low-dose RT and SBRT for locally advanced pancreatic cancer: a prospective trial | Bruno Meduri | ![]() |
![]() |
|||
PO-1048 | Postoperative complications and margins status after neoadjuvant SBRT for pancreatic cancer | Nicola Simoni | ![]() |
![]() |
|||
PO-1049 | Biliary tract tumors: the role of chemoradiotherapy a review of the last 10 years | Virgínia Mareco | ![]() |
![]() |
|||
PO-1052 | Hypofractionated VMAT for Fragile Patients with Oesophageal Cancer | Letizia Deantonio | ![]() |
![]() |
|||
PO-1053 | Involved-field radiation therapy for treatment of locally advanced pancreatic adenocarcinomas. | Gabriela Scalco Munro | ![]() |
![]() |
|||
PO-1054 | Hypofractionated radiotherapy for unresectable esophagus-gastric carcinoma in elderly patients | Fernando López Campos | ![]() |
![]() |
|||
PO-1056 | Chemoradiation for esophageal cancer using carboplatin and paclitaxel: A single centre experience | Asad Qureshi | ![]() |
![]() |
|||
PO-1057 | Influence of brachytherapy on local control of locally advanced esophageal carcinomas | Danijela Scepanovic | ![]() |
![]() |
|||
PO-1058 | Proton beam therapy for hepatocellular carcinoma of caudate lobe | Takashi Iizumi | ![]() |
![]() |
|||
PO-1061 | Stereotactic body radiotherapy for adrenal metastases of oligometastatic or oligoprogressive tumors | Laila Knig | ![]() |
![]() |
|||
PO-1064 | Pancreatic cancer SBRT: reaching consensus in a national survey by AIRO Gastrointestinal Group | Lucrezia Gasparini | ![]() |
![]() |
|||
PO-1065 | Adjuvant chemoradiation (CRT) for gastric cancer: toxicity profile and outcome in Albanian patients | Fatjona Kraja | ![]() |
![]() |
|||
PO-1069 | SBRT in Hepatocellular Carcinoma: impact of dose regimen and treatment sequence | Mauro Loi | ![]() |
![]() |
|||
PO-1070 | Effect of surgery in locally advanced esophageal cancer after chemoradiotherapy | Irene Alda Bravo | ![]() |
![]() |
|||
PO-1071 | Prognostic value of CA19-9 in patients with pancreatic adenocarcinoma after chemoradiotherapy | Yui Nampei | ![]() |
![]() |
|||
PO-1073 | Dosimetric Predictors of Survival in Esophageal Cancers Treated with Preoperative Chemoradiation | Sofia Garcia | ![]() |
![]() |
|||
PO-1074 | Adjuvant radio-chemotherapy after extended or simple cholecystectomy in gallbladder cancer. | Manuel González Domingo | ![]() |
![]() |
|||
PO-1077 | Carbon-ion radiotherapy for hepatocellular carcinoma with vascular invasion | Hirokazu Makishima | ![]() |
![]() |
|||
PO-1078 | Long survivors nature of pancreatic cancer treated with chemoradiotherapy using photon or proton | Yuichi Hiroshima | ![]() |
![]() |
|||
PO-1079 | Systematic review of clinical practice guidelines for colorectal and anal cancer: extent of recommendations for managing long-term symptoms and functional impairments | Lisette Wiltink | ![]() |
![]() |
|||
PO-1080 | C-reactive protein-to-albumin ratio is a predictive marker for anal squamous cell carcinoma | Daniel Martin | ![]() |
![]() |
|||
PO-1081 | Patterns of care analysis of treatment of anal squamous cell carcinoma in German speaking countries | Daniel Martin | ![]() |
![]() |
|||
PO-1082 | Identification of Cell-Free DNA profile in oligometastatic colorectal cancer | Masaki Nakamura | ![]() |
![]() |
|||
PO-1083 | Efficacy and tolerance of VMAT-SIB intensified neoadjuvant chemoradiation in rectal cancer patients | ALESSIA RE | ![]() |
![]() |
|||
PO-1084 | Stereotactic pelvic reirradiation for locoregional cancer relapse | Remy Kinj | ![]() |
![]() |
|||
PO-1087 | Simultaneous integrated boost and volumetric modulated arc radiotherapy in rectal cancer | Bianca-Rose Low | ![]() |
![]() |
|||
PO-1088 | Short Course Radiationtherapy chemotherapy and delayed surgery in locally advanced rectal carcinoma | Swarupa Mitra | ![]() |
![]() |
|||
PO-1089 | Major and complete response after neoadjuvant treatment in rectal cancer: a retrospective analysis | Martina Giraffa | ![]() |
![]() |
|||
PO-1090 | Quality of life among men who have sex with other men treated for anal cancer: Impact of HIV status | Geovanne Pedro Mauro | ![]() |
![]() |
|||
PO-1091 | Quality of life and sexual function of men who have sex with other men treated for anal cancer | Geovanne Pedro Mauro | ![]() |
![]() |
|||
PO-1092 | Clinical results of particle therapy in patients with postoperative recurrence of rectal cancer | Takahiro Waki | ![]() |
![]() |
|||
PO-1093 | Defecography for sphincter evaluation in rectal cancer patients irradiated with dose intensification | Consuelo Rosa | ![]() |
![]() |
|||
PO-1094 | Pathological complete response and outcomes in rectal cancer patients with treatment intensification | Consuelo Rosa | ![]() |
![]() |
|||
PO-1095 | The role of CEA decrease after radical treatment of primary unresectable rectal cancer in predicting the outcome. | Ma&322;gorzata Kraszkiewicz | ![]() |
![]() |
|||
PO-1098 | Dosimetric correlation of acute urinary toxicity in patients with rectal cancer treated with IMRT | Ajra Secerov Ermenc | ![]() |
![]() |
|||
PO-1099 | Response prediction by daily fractional MRI during neoadjuvant radiochemotherapy in rectal cancer | Tilman Bostel | ![]() |
![]() |
|||
PO-1101 | Intensity-modulated radiotherapy treatment of anal cancer: single-institution outcomes | Emily Scott | ![]() |
![]() |
|||
PO-1102 | Dose-volume analysis and sphincter-related toxicity of radiation therapy for rectal cancer | Nicolas Jullian | ![]() |
![]() |
|||
PO-1103 | THE ENERGY METABOLISM CHANGES IN RECTAL CANCER PATIENTS AFTER NEOADJUVANT RADIOCHEMOTHERAPY | Johana Cristina Acosta Arteaga | ![]() |
![]() |
|||
PO-1104 | EFFECT OF NEOADJUVANT RADIOCHEMOTHERAPY ON ACTIVITY OF PARAOXONASE -1 IN RECTAL CANCER PATIENTS | Elizabeth RodriguezTómas | ![]() |
![]() |
|||
PO-1107 | Impact of fractionation on the treatment of squamous cell anal cancer: a dual-institution experience | Marco Vernaleone | ![]() |
![]() |
|||
PO-1109 | Radiotherapy toxicity in older patients with rectal cancer | Edna Darlene Rodrigues Pinto | ![]() |
![]() |
|||
PO-1110 | Bladder dose constraints for conformal radiotherapy in rectal cancer: adaptation to prescribed dose | Nejla Fourati | ![]() |
![]() |
|||
PO-1111 | Pathological lymph node staging for intermediate-risk rectal cancer patients | Akuli Biche | ![]() |
![]() |
|||
PO-1112 | Total neoadjuvant therapy in high risk rectal cancer: a feasibility pilot study | Elisa Palazzari | ![]() |
![]() |
|||
PO-1113 | Intensified IMRT-SIB and capecitabine-based chemotherapy in anal cancer:an institutional experience | Elisa Palazzari | ![]() |
![]() |
|||
PO-1114 | Patient Reported ACute Toxicity of short course radiotherapy with Interval to surgery for rectal CancEr: the PRACTICE study. | Sieske Hoendervangers | ![]() |
![]() |
|||
PO-1115 | WHATS THE ROLE OF TUMOR REGRESSION GRADE (TRG) IN RECTAL CANCER: AN ISTUTUTIONAL EXPERIENCE | Annamaria Guaineri | ![]() |
![]() |
|||
PO-1116 | CERVICAL CANCER PATTERNS OF CARE IN ITALY: A RADIATION ONCOLOGY SURVEY OF MITO AND AIRO GYN GROUPS | Gabriella Macchia | ![]() |
![]() |
|||
PO-1117 | Two-step adaptive 3-D conformal brachytherapy for advanced bulky cervical cancer | Ick Joon Cho | ![]() |
![]() |
|||
PO-1118 | The dilemma of cervical cancer during pregnancy. A 10 year single-center experience | Lucía Juan Rodríguez | ![]() |
![]() |
|||
PO-1119 | Sexual Toxicity in Cervix Cancer Survivors Treated with Chemo-Radiation and MR-guided Brachytherapy | Jennifer Croke | ![]() |
![]() |
|||
PO-1120 | Exploring Brachytherapy Educational Needs of Cervical Cancer Patients | Jennifer Croke | ![]() |
![]() |
|||
PO-1122 | Sexual function in cervical cancer patients treated with definitive chemoradiation in South Africa | Prinitha Pillay | ![]() |
![]() |
|||
PO-1124 | Impact of lymph node dissection on adjuvant radiotherapy in endometrial cancer. | Emma Doyle | ![]() |
![]() |
|||
PO-1125 | Qol records filled by patient or psychologist? Ns. experience in sexual dysfunction (DS) after RT. | FABRIZIO PIRO | ![]() |
![]() |
|||
PO-1126 | Clinical experience of pelvic radiotherapy for postoperative uterine cervical cancer using VMAT | Takaya Yamamoto | ![]() |
![]() |
|||
PO-1127 | Acute and late toxicity report of post-operative IG-IMRT for gynecological malignancies | Francesco Cuccia | ![]() |
![]() |
|||
PO-1129 | Impact of individualized ITV margins for IMRT of cervical cancer on target coverage | Kentaro Wada | ![]() |
![]() |
|||
PO-1133 | Concurrent chemoradiotherapy with or without brachytherapy; a retrospective clinical study | Khadidja Boudaoud | ![]() |
![]() |
|||
PO-1134 | 18F-FDG-PET/CT role in the adjuvant setting of endometrial cancer | Martina Ferioli | ![]() |
![]() |
|||
PO-1135 | Place of radiotherapy as part of multimodal management of cervical glassy cell carcinoma | Jihane Boustani | ![]() |
![]() |
|||
PO-1138 | Quality of life in vaginal brachytherapy for endometrial carcinoma IN THE ELDERLY. | Rosario Rubiato Aragón | ![]() |
![]() |
|||
PO-1140 | Role of Functional Imaging in evaluation of Radiation Colitis | ANKUSH JAJODIA | ![]() |
![]() |
|||
PO-1141 | Prognostic factors in gynaecological cancer patients treated with radiotherapy for brain metastases | Esten Nakken | ![]() |
![]() |
|||
PO-1144 | Adjuvant electronic brachytherapy for patients with endometrial cancer. | Arantxa Campos | ![]() |
![]() |
|||
PO-1145 | Radiotherapy-induced changes in lymphocytes count important for immunotherapy of uterine cancers | Katarzyna Holub | ![]() |
![]() |
|||
PO-1146 | Evaluation of Dose to pelvic lymphnodes in CT-based High DoseRate Brachytherapy in Carcinoma Cervix | Swarupa Mitra | ![]() |
![]() |
|||
PO-1147 | Salvage radiotherapy for recurrent endometrial cancer: predictors of outcome. | Hanan Almasri | ![]() |
![]() |
|||
PO-1148 | Implementation of a cervix cancer specific patient reported outcome measure in clinical practice | Jennifer Croke | ![]() |
![]() |
|||
PO-1151 | Is the dose-distribution in bladder really unimportant for GU toxicity in prostate cancer patients? | Wojciech Majewski | ![]() |
![]() |
|||
PO-1153 | Isolated bone metastases in prostate patients: preliminary analysis from two phase I trials on SRS | Francesco Deodato | ![]() |
![]() |
|||
PO-1155 | The Impact of Undetectable PSA After Salvage Radiotherapy for Prostate Cancer | Isabel Rodrigues | ![]() |
![]() |
|||
PO-1156 | THE ROLE OF MAGNETIC RESONANCE IMAGING IN PROSTATE CANCER | Elísabet González Del Portillo | ![]() |
![]() |
|||
PO-1157 | Short-term results of coverage probability radiotherapy of MRI-staged prostate cancer | Jolanta Marzec | ![]() |
![]() |
|||
PO-1159 | Toxicity Profile in Postoperative Radiotherapy for Prostate Cancer with Moderate Hypofractionation | Pietro Pacifico | ![]() |
![]() |
|||
PO-1160 | A pilot dual-platform transcriptomic analysis of diagnostic prostate biopsies & radical RT response | Philip charlton | ![]() |
![]() |
|||
PO-1161 | The first study in outcomes and toxicity of VMAT as a curative for prostate cancer in Southeast Asia | Pittaya Dankulchai | ![]() |
![]() |
|||
PO-1165 | Toxicity and outcomes of postoperative hypofractionated Helical Tomotherapy for prostate cancer | Francesco Cuccia | ![]() |
![]() |
|||
PO-1166 | IMRT versus 3D-CRT in the treatment of prostate cancer: comparison of outcomes and toxicity. | Wei Guo | ![]() |
![]() |
|||
PO-1167 | Salvage therapies for PSMA PET-positive nodal recurrent prostate cancer | Nina-Sophie Schmidt-Hegemann | ![]() |
![]() |
|||
PO-1169 | Influence of localisation of PSMA-positive oligo-metastases on efficacy of metastasis-directed EBRT | Nina-Sophie Schmidt-Hegemann | ![]() |
![]() |
|||
PO-1171 | Low- and Intermediate-Risk Prostate Cancer. Stereotactic Body Radiation Therapy. Our experience. | Cristina García Aguilera | ![]() |
![]() |
|||
PO-1172 | Dose effects due to interfractional variability for hypofractionated radiotherapy of prostate Cancer | Mona Splinter | ![]() |
![]() |
|||
PO-1173 | Long term results of IG-IMRT in high risk prostate cancer patients: a monoinstitutional experience | Nadia Di Muzio | ![]() |
![]() |
|||
PO-1174 | Results of a multinational clinical audit for prostate cancer radiotherapy: the IROCA project | Carla Lopes de Castro | ![]() |
![]() |
|||
PO-1175 | SBRT for localised prostate cancer Nordic results with mFU of 5.3 years | Kristiina Vuolukka | ![]() |
![]() |
|||
PO-1176 | Ultra-hypofractionated SBRT for localized prostate cancer: single institution experience | Angel Jose Acosta Rojas | ![]() |
![]() |
|||
PO-1177 | Treatment-related toxicity using prostate only vs prostate and pelvic lymph node radiation therapy. | Matthew Parry | ![]() |
![]() |
|||
PO-1178 | Identifying skeletal-related events for prostate cancer in routinely collected hospital data. | Matthew Parry | ![]() |
![]() |
|||
PO-1179 | Patient-reported outcomes following a high-dose rate brachytherapy boost for prostate cancer. | Matthew Parry | ![]() |
![]() |
|||
PO-1180 | Patterns of failure after stereotactic ablative radiotherapy for abdomino-pelvic nodal disease | Finbar Slevin | ![]() |
![]() |
|||
PO-1181 | Metastasis-Directed Therapy influence in clinical outcomes of oligorrecurrent prostate cancer | Alba Gonzalez Lopez | ![]() |
![]() |
|||
PO-1182 | PSMA-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for ADT deferral in patients with oligometastatic prostate cancer | Charlotte Deijen | ![]() |
![]() |
|||
PO-1183 | Do we need sigma constraints in era of intensity-modulated radiation therapy for prostate cancer? | Fabiola Patani | ![]() |
![]() |
|||
PO-1185 | Results of prostate cancer patients treated by integrated boost to dominant intraprostatic lesion | Anna Rita Alitto | ![]() |
![]() |
|||
PO-1186 | Impact of a low FODMAP diet on rectal gas and rectal volume during radiotherapy of prostate cancer | Christian Schaefer | ![]() |
![]() |
|||
PO-1189 | VMAT SBRT for localized prostate cancer: 5-year update on toxicity and survival | Giuseppe Roberto DAgostino | ![]() |
![]() |
|||
PO-1190 | The 100 most cited articles in prostate cancer brachytherapy: A bibliometric study | Hongfu Zhao | ![]() |
![]() |
|||
PO-1191 | SIB-VMAT for DIL in prostate cancer: the preliminary result in acute toxicity and quality of life | Wiwatchai Sittiwong | ![]() |
![]() |
|||
PO-1192 | Elective Pelvic Nodes Irradiation in Patients with Prostate Cancer (PRO-EPI Study) | Michela Bugllione | ![]() |
![]() |
|||
PO-1193 | 18F-CHOLINE PET/68Ga-PSMA PET SBRT IN OLIGORECURRENT PROSTATE CANCER: COMPARATIVE ANALYSIS | Rosario Mazzola | ![]() |
![]() |
|||
PO-1195 | Impact of Adjuvant Radiotherapy in node positive prostate cancer patients | Giulia Corrao | ![]() |
![]() |
|||
PO-1196 | Long term results with moderately hypofractionated RT in high-risk localized prostate cancer. | Shaurav Maulik | ![]() |
![]() |
|||
PO-1197 | Short-term high precision RT for early PCa with SIB to the DIL: QoL assessment (AIRC IG 13218) | Giulia Marvaso | ![]() |
![]() |
|||
PO-1199 | Rectal toxicity prostate cancer treated with Brachytherapy: a radiomics-machine learning based NTCP | Gurvan Dissaux | ![]() |
![]() |
|||
PO-1202 | CHHiPvsPROFIT for Localized Prostate Cancer:A Retrospective Dosimetric Comparison of Organs at Risk. | Paul Ramia | ![]() |
![]() |
|||
PO-1204 | CLINICAL OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH LOCALIZED PROSTATE CANCER TREATED HDR BT | Durim Delishaj | ![]() |
![]() |
|||
PO-1205 | Small cell carcinoma of the bladder: Retrospective long-term outcomes of chemoradiation | Justin Oh | ![]() |
![]() |
|||
PO-1206 | Immune response gene expression analysis and response to radical chemoradiation in bladder cancer | Milan Anjanappa | ![]() |
![]() |
|||
PO-1207 | Exploring molecular subtype as a biomarker of radiation response in muscle-invasive bladder cancer | Melissa Tan | ![]() |
![]() |
|||
PO-1208 | High-dose rate brachytherapy in the treatment of early stages of penile carcinoma | Igor Sirák | ![]() |
![]() |
|||
PO-1209 | A novel liquid fiducial marker for image-guided adaptive radiotherapy in bladder cancer. | Mischa de Ridder | ![]() |
![]() |
|||
PO-1210 | Local treatment on the outcome of immune-checkpoint inhibitors in metastatic urothelial carcinoma | Xavier Maldonado | ![]() |
![]() |
|||
PO-1211 | Stereotactic radiotherapy combined with immune- or targeted therapy for renal cell cancer patients. | Stephanie Kroeze | ![]() |
![]() |
|||
PO-1215 | Impact of bladder size at radiotherapy planning scan on survival | Yee Pei Song | ![]() |
![]() |
|||
PO-1216 | Can sarcopenia predict outcomes in bladder cancer patients treated with chemoradiotherapy? | Michael Corden | ![]() |
![]() |
|||
PO-1217 | Safety of Nivolumab and stereotactic RT in metastatic renal carcinoma: early results of NIVES study | Patrizia Ciammella | ![]() |
![]() |
|||
PO-1218 | Oligo Metastatic renal cell carcinoma: SBRT, if, when and how? | Giulia Marvaso | ![]() |
![]() |
|||
PO-1219 | Primary Bladder Sarcoma: a multi-institutional experience from the Rare Cancer Network. | Piero Bettoli | ![]() |
![]() |
|||
PO-1220 | Organ-preserving treatment for muscle-invasive bladder cancer: outcomes and prognostic factors | Martine Franckena-Schouten | ![]() |
![]() |
|||
PO-1221 | Dose-volume predictors of distal urethral toxicity after PDR brachytherapy for penile carcinoma | Samir Achkar | ![]() |
![]() |
|||
PO-1222 | Radiotherapy for non-melanoma skin cancer: three different radiation techniques comparison | Miguel Arquez Pianetta | ![]() |
![]() |
|||
PO-1223 | SUPERFICIAL RADIOTHERAPY IN EPITHELIAL SKIN CANCER | Sonia Blanco Parajón | ![]() |
![]() |
|||
PO-1224 | Clinical Outcomes of Immune Checkpoint Blocker Therapy for Malignant Melanoma in Korean Patients: Potential Clinical Implications for a Combination Strategy Involving Radiotherapy | JEONGSHIM LEE | ![]() |
![]() |
|||
PO-1225 | Skin radiotherapy training programme for dermatology specialty trainees - an unmet need | Agata Rembielak | ![]() |
![]() |
|||
PO-1226 | Safety and outcomes of concurrent immunotherapy and radiation therapy for melanoma brain metastases | Andréa Desagneaux | ![]() |
![]() |
|||
PO-1227 | A dose escalation phase 1 study of radiotherapy combined with ipilimumab in metastatic melanoma. | CELINE BOUTROS | ![]() |
![]() |
|||
PO-1229 | Preliminary data on long term toxicity in young patients with chordoma: C.N.A.O. experience | Esmeralda Scipilliti | ![]() |
![]() |
|||
PO-1232 | Patients with pelvic Ewing Sarcoma with metastases at time of diagnosis: a monocentric experience | Letizia Ronchi | ![]() |
![]() |
|||
PO-1233 | Perioperative Radiotherapy with a Moderate Dose-Escalation for Retroperitoneal Sarcoma (RPS). | MONICA NUÑEZ | ![]() |
![]() |
|||
PO-1234 | RT With Hyperthermia in Locally Advanced Soft Tissue Sarcomas: Interim Analysis of Phase II Trial | Mateusz Spalek | ![]() |
![]() |
|||
PO-1236 | Re-irradiation for recurrent spinal chordomas with high-dose stereotactic body radiation therapy | Chunzi Jenny Jin | ![]() |
![]() |
|||
PO-1237 | Assessing the role of IMRT relative to VMAT in children with medulloblastoma treated with CSI | Warissara Rongthong | ![]() |
![]() |
|||
PO-1238 | Dosimetric study comparing IMRT to VMAT in completed resection pediatric abdominal neuroblastoma | Teeradon Treechairusame | ![]() |
![]() |
|||
PO-1239 | Post-TBI amylase value as a prognostic marker for transplant outcomes in the pediatric population | Francesco Baldo | ![]() |
![]() |
|||
PO-1240 | Permanent alopecia after cranial irradiation in childhood cancer survivors. | Escande Alexandre | ![]() |
![]() |
|||
PO-1243 | 20 years trend in the paediatric radiooncology: monocentric analysis | Montserrat Pazos | ![]() |
![]() |
|||
PO-1245 | Novel approach in bone metastasis with neuropathic pain: palliative radiotherapy with tapentadol? | Jon Cacicedo | ![]() |
![]() |
|||
PO-1246 | STEREOTACTIC BODY RADIOTHERAPY FOR BONE METASTASES IN OLIGOMETASTATIC-OLIGOPROGRESSIVE PATIENTS | Flavia Zerbetto | ![]() |
![]() |
|||
PO-1247 | Analysis on early death in patients after radiotherapy: Should we change practice? | Rebecca Asadpour | ![]() |
![]() |
|||
PO-1248 | Preliminary safety and survival report of Stereotactic radiotherapy to oligometastases. | Nikesh Hanumanthappa | ![]() |
![]() |
|||
PO-1250 | Palliation of vertebral metastases and cord compressions: single field or VMAT? | Nick West | ![]() |
![]() |
|||
PO-1251 | Whole brain radiotherapy: to treat or not to treat? | Lijanne Otto-Vollaard | ![]() |
![]() |
|||
PO-1253 | Stereotactic Ablative Radiotherapy for spinal metastases: Experience at a Brazilian Institution | Gustavo Marta | ![]() |
![]() |
|||
PO-1254 | Palliative QUAD shots with chemotherapy in advanced Head and Neck Cancer: Is it the way to go? | Poornachandra Tejaswi | ![]() |
![]() |
|||
PO-1256 | Feasibility and initial results of Linac-based Stereotactic Body Radiotherapy in spinal metastases | niccolo giaj levra | ![]() |
![]() |
|||
PO-1257 | Use of Stereotactic Radiotherapy in lymph nodes for oligometastic pelvic tumors | Annaisabel Rese | ![]() |
![]() |
|||
PO-1258 | Intensity modulated radiation therapy for lymph node oligo-recurrence | Akiko Sato | ![]() |
![]() |
|||
PO-1259 | Adoption of single-fraction radiotherapy for uncomplicated bone metastases in a tertiary centre | Cedric Peters | ![]() |
![]() |
|||
PO-1261 | Radiation pneumonitis after palliative radiotherapy in patients with interstitial lung disease | Masayuki Okumura | ![]() |
![]() |
|||
PO-1264 | The role of adjuvant treatment in older population with early stage oral cavity cancer. | Fang-Yi Lin | ![]() |
![]() |
|||
PO-1266 | Radical radiotherapy in elderly prostate cancer patients: a monoinstitutional experience. | fulvio borroni | ![]() |
![]() |
|||
PO-1268 | Survival prediction in geriatric patients after radiotherapy of spinal bone metastases | Tilman Bostel | ![]() |
![]() |
|||
PO-1269 | Intensity Modulated Radiotherapy for pelvic tumors in elderly patients with colic diverticulosis | Fiorella Cristina Di Guglielmo | ![]() |
![]() |
|||
PO-1271 | LUNG STEREOTACTIC ABLATIVE RADIOTHERAPY IN ELDERLY PATIENTS: SAFETY AND EFFICACY. | Chiara Cavallin | ![]() |
![]() |
|||
PO-1273 | Infrastructure and staffing in the EORTC Radiation Oncology Groups international network | Jonas Willmann | ![]() |
![]() |
|||
PO-1274 | Variations in IMRT demand and delivery across England | Thomas Mee | ![]() |
![]() |
|||
PO-1275 | Implementation of MR-Linac into routine prostate cancer care: opportunities & challenge ges | Charisma Hehakaya | ![]() |
![]() |
|||
PO-1276 | A National survey on the Radiation Oncology resources for the treatment of Head and Neck Cancer. | Joaquin Jose Cabrera Rodriguez | ![]() |
![]() |
|||
PO-1277 | Network of Radiotherapy Cancer Centers in Sardinia: equipment, staff and access to care | Salvatrice Campoccia | ![]() |
![]() |
|||
PO-1278 | Process mining for the optimization of palliative patients workflow in a radiotherapy department | Lorenzo Placidi | ![]() |
![]() |
|||
PO-1279 | More intelligent workflow in a radiation oncology center with the implementation of LEAN thinking | Escarlata Lopez Ramirez | ![]() |
![]() |
|||
PO-1280 | SIX-YEARS EXPERIENCE OF PEER REVIEW: Analysis of results and lessons learned | Jaime Perez-Alija | ![]() |
![]() |
|||
PO-1281 | Heterogeneity in radiation oncology training, a problem that calls for attention in Latin America | David Antonio Martinez Perez | ![]() |
![]() |
|||
PO-1284 | Evaluation of the Effectiveness of Telehealth Courses for SBRT/SRS Training in Latin America | David Antonio Martinez Perez | ![]() |
![]() |
|||
PO-1285 | Gender disparity among United States academic oncology program leadership | Mudit Chowdhary | ![]() |
![]() |
|||
PO-1287 | Quality of life (QL) in elderly breast cancer survivors. Effects of surgery. Global QL determinants | Juan Ignacio Arraras | ![]() |
![]() |
|||
PO-1288 | R Shiny and Flexdashboards: Utilizing Open Source Tools for Interactively Tracking Clinical Trials | Michael Golafshar | ![]() |
![]() |
|||
PO-1289 | Patient Reported Outcomes: Using ESAS to screen for anemia | Peter Johnstone | ![]() |
![]() |
|||
PO-1290 | 100 peer review in radiation oncology. Is it feasible? | Francisco Javier Celada Alvarez | ![]() |
![]() |
|||
PO-1291 | Management of pain in Radiotherapy Departments: preliminary results of an observational study | Costanza Maria Donati | ![]() |
![]() |
|||
PO-1292 | Radiation planning parameters correlate with peripheral immune status during prostate radiotherapy | Franziska Eckert | ![]() |
![]() |
|||
PO-1293 | The forgotten history of Leopold Freund as a victim of Nazi policies in Vienna 1938/1939 | Franziska Eckert | ![]() |
![]() |
|||
PO-1294 | Consistency of OAR delineation for clinical trials: A Global Harmonization Group Consensus | Romaana Mir | ![]() |
![]() |
|||
PO-1295 | RAMSI: patients satisfaction by Smile In Totem in a mono-institutional experience in radiotherapy | Andrea DAviero | ![]() |
![]() |
|||
PO-1298 | Acute Toxicities and Compliance of 551 consecutive patients treated with Cyberknife, Indian institute experience | Ajinkya Gupte | ![]() |
![]() |
|||
PO-1299 | Prospective clinical evaluation of feasibility and patient acceptance of MR-guided radiotherapy | Sebastian Klter | ![]() |
![]() |
|||
PO-1300 | Manufactured 3D imaging treatment table for image-guided brachytherapy | Papp Judit | ![]() |
![]() |
|||
PO-1302 | Management and safety report for patients with cardiac implantable electronic device in radiotherapy | Saide Di Biase | ![]() |
![]() |
|||
PO-1303 | Radiotherapy platform trials: accelerating our ability to answer important scientific questions | Alexandra Gilbert | ![]() |
![]() |
|||
PO-1305 | Effectiveness and safety evaluation of radiotherapy for Painful Heel Spur Syndrome. | Tomasz Latusek | ![]() |
![]() |
|||
PO-1306 | Pilot study: Characteristics of N-isopropyl acrylamide polymer gel dosimetry with proton beam | Yuan-Jen Chang | ![]() |
![]() |
|||
PO-1307 | IPEM Code of Practice for high-energy photon dosimetry based on the NPL dose calibration service | David Eaton | ![]() |
![]() |
|||
PO-1308 | Relative Dose Measurements in Diagnostic Radiology Beams Using the XR-QA2 GafChromicTM Film Model | Nada Tomic | ![]() |
![]() |
|||
PO-1309 | Dosimetric Impact of Respiratory Motion in IMRT for breast cancer: 3D-Printed Dynamic Phantom Study | Young Eun Choi | ![]() |
![]() |
|||
PO-1310 | Gamma Knife Relative Output Factor Measurements with Multichannel Radiochromic Film Dosimetry | Mahta McKee | ![]() |
![]() |
|||
PO-1311 | Dosimetric evaluation of a 2D multidetector dedicated to stereotactic radiotherapy | Villeneuve Rémy | ![]() |
![]() |
|||
PO-1312 | Diffusion-weighted imaging evaluation using a 3D-printed phantom for Stereotactic Radiosurgery | Tarraf Torfeh | ![]() |
![]() |
|||
PO-1313 | Population-based virtual phantoms for paediatric radiotherapy applications initial developments | Catarina Veiga | ![]() |
![]() |
|||
PO-1314 | Creation of a 3D-printed plastic mouse phantom for pre-clinical dosimetry and quality assurance | Severin Kampfer | ![]() |
![]() |
|||
PO-1315 | Development and Evaluation of Flexible Dosimeter for Surface Dose Measurement in Radiotherapy | JinYoung Kim | ![]() |
![]() |
|||
PO-1316 | Real-time fibered X-ray dosimeter for small field dosimetry in high energy radiation oncology | Sree Bash Chandra Debnath | ![]() |
![]() |
|||
PO-1317 | Experimental determination of kBMQ up to a magnetic flux density of 1.5 T | Stefan Pojtinger | ![]() |
![]() |
|||
PO-1319 | Design of a phantom for verification of IORT treatments and in vivo dosimetry simulation. | Sergio Lozares | ![]() |
![]() |
|||
PO-1320 | A machine QA tool to verify targeting accuracy of off-isocenter metastases | Haris Kudrolli | ![]() |
![]() |
|||
PO-1322 | Advanced Marcus chamber in high dose-per-pulse electron beams.kpol and ksat inter-chamber dependence | Jose Chimeno | ![]() |
![]() |
|||
PO-1323 | Comparison of three commercial detectors with Monte Carlo Simulation for measurement of Field Output factor for small field | Dalila Mateus | ![]() |
![]() |
|||
PO-1324 | Small field output factors measurement with EBT3 gafchromic film in water | Carlos Ferrer | ![]() |
![]() |
|||
PO-1325 | Measurement and MC simulation of magnetic field correction factors of compact ionization chambers | Isabel Bsing | ![]() |
![]() |
|||
PO-1326 | Evaluation of Percentage Depth Dose Measurement of High-energy Electron Beams using new TLD Sheet | Koji Sasaki | ![]() |
![]() |
|||
PO-1327 | Performances of new beam monitors based on Ultra Fast Silicon Detectors for proton therapy | Zahra Shakarami | ![]() |
![]() |
|||
PO-1328 | Ionization quenching correction for 3D scintillator detectors for spot scanning proton therapy | Fahed Alsanea | ![]() |
![]() |
|||
PO-1329 | Characterisation of a scintillator for small fields and in-vivo dosimetry in MR guided Radiotherapy | Davide Cusumano | ![]() |
![]() |
|||
PO-1330 | On the Implementation and Validation of 3D Computational Pediatric Phantoms in Commercial TPS | Aashish Gupta | ![]() |
![]() |
|||
PO-1331 | Monte Carlo assessment of the PTW-31021 Semiflex 3D performance under a 0.35 tesla magnetic field | Grichar Valdes Santurio | ![]() |
![]() |
|||
PO-1332 | Evaluation of IAEA small field correction factors using different detectors for FF and FFF energies | Gloria Beyer | ![]() |
![]() |
|||
PO-1334 | Feasibility of the kQQ0 formalism for Farmer-type chambers in medium-energy kV x-ray beams | Massimo Pinto | ![]() |
![]() |
|||
PO-1335 | Characterization of novel 3D printed plastic scintillation dosimeters | Nicholas Lynch | ![]() |
![]() |
|||
PO-1336 | Should we include machine uncertainties in radiotherapy planning? | Peter Haering | ![]() |
![]() |
|||
PO-1337 | Pre-treatment verification of multi-target SRS using a virtual water phantom | JUAN-FRANCISCO CALVO-ORTEGA | ![]() |
![]() |
|||
PO-1338 | Validation of the rotation induced couch shift with the Machine Performance Check (MPC) tool | Marco Parisotto | ![]() |
![]() |
|||
PO-1341 | Monte Carlo secondary plan check: validation and definition of the action limits for patient QA | Irina Fotina | ![]() |
![]() |
|||
PO-1342 | An efficient setup for weekly dose output constancy of a 1.5T MR-Linac | BIN YANG | ![]() |
![]() |
|||
PO-1343 | Measurement of surface dose in a 1.5 T MR-Linac using plane-parallel ionization chamber | BIN YANG | ![]() |
![]() |
|||
PO-1345 | Defining Tumor Treating Fields (TTFields) dosimetry based on power loss density and related measures | Zeev Bomzon | ![]() |
![]() |
|||
PO-1346 | In-vivo surface dose measurements in breast cancer patient treated with helical radiation therapy | Marco Valenti | ![]() |
![]() |
|||
PO-1347 | Halcyon commissioning using a 3D water phantom: beam data validation and initial end-to-end tests | Daniel San José Olmedo | ![]() |
![]() |
|||
PO-1349 | GEOMETRIC AND DOSIMETRIC CRITICAL ISSUES IN IORT BY MOBILE LINACS | STEFANO ANDREOLI | ![]() |
![]() |
|||
PO-1350 | In vivo dosimetry with XR-RV3 radiochromic films in intraoperative radiotherapy of the breast | Sergio Lozares | ![]() |
![]() |
|||
PO-1351 | One fits all? The influence of phantom ion on pre-treatment verification results | Agnieszka Walewska | ![]() |
![]() |
|||
PO-1353 | Validation of a commercial software for in vivo patient Quality Assurance | Cinzia Talamonti | ![]() |
![]() |
|||
PO-1354 | Are we on the safe side? Action and tolerance limits for verification of IMRT and VMAT plans | Agnieszka Walewska | ![]() |
![]() |
|||
PO-1355 | Analyzing Tumor Treating Fields (TTFields) delivery by Water-based electrical properties tomography | Zeev Bomzon | ![]() |
![]() |
|||
PO-1357 | Creating individually computed head models to simulate TTFields distribution | Zeev Bomzon | ![]() |
![]() |
|||
PO-1358 | In vivo measurements in sarcoma radiotherapy | Agnieszka Walewska | ![]() |
![]() |
|||
PO-1360 | Impact of plan parameters in gamma passing rates in VMAT QA | Ana Garcia Perez | ![]() |
![]() |
|||
PO-1361 | Treatment plan preparation and verification for total body irradiation using tomotherapy | Ewelina Konstanty | ![]() |
![]() |
|||
PO-1363 | Dosimetric impact of leaf open time and other planning parameters on DQA in helical tomotherapy | Kyung Hwan Chang | ![]() |
![]() |
|||
PO-1365 | EPID 2D transit In Vivo Dosimetry: Can relevant anatomy and positioning differences be detected? | nuria jornet | ![]() |
![]() |
|||
PO-1366 | Comparison of Acuros and Anisotropic Analytical Algorithm for dose calculations in VMAT treatments | Eva Maria Ambroa Rey | ![]() |
![]() |
|||
PO-1367 | Patient-QA prediction: a new approach of complexity indexes. | Daniel Julian | ![]() |
![]() |
|||
PO-1369 | Stability of machine QA parameters for a 1.5&8201;T MR-linac in the first year after installation | Jasmin Winter | ![]() |
![]() |
|||
PO-1371 | A feasibility study of using TomoTherapy exit detector data for pretreatment verification | Marco Parisotto | ![]() |
![]() |
|||
PO-1372 | Feasibility of treatment planning on contrast enhanced CTs for H&N cancer | Manuela Gober | ![]() |
![]() |
|||
PO-1373 | Evaluation of X-ray beam focal spot position for Varian TrueBeam linear accelerators | Ola Juda | ![]() |
![]() |
|||
PO-1374 | Validation of SRS MapCheck for patient specific QA | Cristina Anson Marcos | ![]() |
![]() |
|||
PO-1375 | Portal dosimetry prediction using Pinnacle TPS for clinical quality assurance applications. | Maher Fawzi | ![]() |
![]() |
|||
PO-1378 | Radiation attenuation comparison of the couch and coil structures for two Unity MR-Linacs | David Tilly | ![]() |
![]() |
|||
PO-1379 | Quantifying the errors associated with the AAA in the presence of high-density implants | Andrea Fischer | ![]() |
![]() |
|||
PO-1380 | Validation of the PRIMO Monte Carlo software for stereotactic radiosurgery plans | Marcelino Hermida-López | ![]() |
![]() |
|||
PO-1381 | Performance in clinical conditions of the dual-layer multileaf collimator from a Halcyon 2.0 linac | Marcelino Hermida-López | ![]() |
![]() |
|||
PO-1383 | Comparing the error detection performance of Portal Dosimetry & PerFraction in pre-treatment VMAT QA | Stephen Moloney | ![]() |
![]() |
|||
PO-1384 | Assessing Ir-192 as an alternative to I-125 in ophthalmic treatment | Lucas Angelocci | ![]() |
![]() |
|||
PO-1385 | CyberKnife patient plan verification with the SRS MapCHECKTM - First clinical experience | Sarah Peters | ![]() |
![]() |
|||
PO-1386 | Validation of a MC software for the QA of patients treated with modulated intensity photon beams | Stefano Piffer | ![]() |
![]() |
|||
PO-1387 | Correlation between gamma analysis results and monitor units in prostate VMAT | María Gil Conde | ![]() |
![]() |
|||
PO-1388 | Dosimetric accuracy of MRCAT Pelvis, an MR-only simulation method for RT planning in the pelvic area | Gregory Bolard | ![]() |
![]() |
|||
PO-1389 | Experimental validation of the ripple effect of lung tissue equivalent materials in a proton beam | Barbara Knusl | ![]() |
![]() |
|||
PO-1391 | Dosimetric measurements with Gafchromic EBT-3 films for the Papillon intraoperative therapy system | Claudine Colnard-Hofverberg | ![]() |
![]() |
|||
PO-1392 | Are the universal limits recommended by TG218 suitable for VMAT QA regardless of technical solution? | Giuseppe Della Gala | ![]() |
![]() |
|||
PO-1393 | Monte Carlo simulation of a Varians TrueBeam linac as a Clinac 2100: A feasibility study. | Miguel Rodriguez | ![]() |
![]() |
|||
PO-1394 | A revisited recipe for targeted linac QA: precise, efficient, and tailored to current needs | Christian Clermont | ![]() |
![]() |
|||
PO-1397 | Validation of two different Monte Carlo engines for secondary independent dose calculation. | Stefan Hofer | ![]() |
![]() |
|||
PO-1398 | Validation and clinical Implementation of Sun Nuclear DoseCHECK and PerFRACTION for Varian Halcyon | Ewan Almond | ![]() |
![]() |
|||
PO-1399 | Evaluation of SRS MapCHECK for SABR patient-specific QA | Yun Miao | ![]() |
![]() |
|||
PO-1400 | Dose distribution uncertainties in low dose regions: comparison between the AAA and Acuros XB dose calculation algorithms in radiotherapy for brain metastases | Mohammed Alahmari | ![]() |
![]() |
|||
PO-1404 | Safe number of transfer fractions between Varian Truebeam and Varian Clinac linear accelerator for different treatment sites without re-planning. | Trevor Newbold | ![]() |
![]() |
|||
PO-1407 | Sensitivity of Octavius 4D system in detecting systematic or incidental MLC positioning errors | Chin Loon Ong | ![]() |
![]() |
|||
PO-1408 | End-to-end empirical validation of 3D dose distributions using an anthropomorphic pelvis phantom | Mathieu Marot | ![]() |
![]() |
|||
PO-1409 | Optimization of the Halcyon accelerator quality control system | Maciej Raczkowski | ![]() |
![]() |
|||
PO-1410 | Trend lines of patient specific quality assurance in light-ion beam therapy | Mansure Schafasand | ![]() |
![]() |
|||
PO-1411 | Commissioning of Tomotherapy treatment planning in RayStation | Kai Schubert | ![]() |
![]() |
|||
PO-1412 | A method for determining dosimetric leaf separation of a multileaf collimator | Antti Kulmala | ![]() |
![]() |
|||
PO-1413 | Ion chamber beam quality correction factors for brachytherapy dosimetry measurements | Zoi Thrapsanioti | ![]() |
![]() |
|||
PO-1414 | Determination of dosimetric leaf gap (DLG) for FFF and WFF beams for a high definition MLC | Cristina Anson Marcos | ![]() |
![]() |
|||
PO-1415 | Validating a commercial solution for calculation-based QA of AI-driven online adaptive radiotherapy | Patrik Sibolt | ![]() |
![]() |
|||
PO-1416 | Dose calculation algorithm for a compact x-ray source in Microbeam Radiation Therapy | Mabroor Ahmed | ![]() |
![]() |
|||
PO-1418 | Left breast radiotherapy: what is the dose received by the left ventricle ? | Aissaoui Dorra | ![]() |
![]() |
|||
PO-1419 | Is it possible to reduce the number of DQAs with Tomotherapy HD using Statistical Process Control? | Sandra LOSA | ![]() |
![]() |
|||
PO-1420 | 2/2mm Gamma index analysis in routine EPID verification of conventional fractionated VMAT plans | Anna Zaleska | ![]() |
![]() |
|||
PO-1421 | Investigating dose calculation accuracy around gas-filled tissue expanders using 3D-printed phantoms | Tanya Kairn | ![]() |
![]() |
|||
PO-1422 | Monte Carlo study of dose deposition in kilovoltage X-ray radiotherapy using gold as dose enhancer | Jenny Spiga | ![]() |
![]() |
|||
PO-1423 | Ionizing radiation dose-effect indicator for cancer risks in medical radiation personnel | Saman Shahid | ![]() |
![]() |
|||
PO-1425 | Secondary cancer risk in breast cancer patients treated with protons compared to 3D-CRT and VMAT | Francesco Tommasino | ![]() |
![]() |
|||
PO-1426 | A Comparative Study for Dose Length Product (DLP) Methods of Cone Beam CT Scans | Abdullah Abuhaimed | ![]() |
![]() |
|||
PO-1427 | Comparison of Flattening Filter (FF) and Flattening-Filter-Free (FFF) out of field surface doses | Maria Trinidad García Hernández | ![]() |
![]() |
|||
PO-1428 | Size-Specific Dose Estimates (SSDEs) Factors for Head Scans of Different Imaging Systems | Abdullah Abuhaimed | ![]() |
![]() |
|||
PO-1429 | Risk for radiation-induced cancer following proton vs.photon radiotherapy of mediastinal lymphoma | Laila Knig | ![]() |
![]() |
|||
PO-1430 | A Monte Carlo Study of Infinitely Long Phantoms Used for CT Dosimetry | Abdullah Abuhaimed | ![]() |
![]() |
|||
PO-1431 | Patient-specific dose calculations from a proton gantry mounted CBCT system: implementation in TOPAS | Thomas Henry | ![]() |
![]() |
|||
PO-1434 | THOROUGH ASSESSMENT OF A NEW COMMERCIAL TOOL TO REDUCE PLAN COMPLEXITY | Alessandro Scaggion | ![]() |
![]() |
|||
PO-1435 | Large treatment plan quality enhancement in robotic radiotherapy | Marta Gi&380;y&324;ska | ![]() |
![]() |
|||
PO-1436 | The potential of robust photon treatment planning for internal mammary lymph node-positive breast cancer | Ruben Vissers | ![]() |
![]() |
|||
PO-1437 | Treatment plan robustness analysis for high field MR-linac partial breast plans | Robert Adam Mitchell | ![]() |
![]() |
|||
PO-1438 | Automated proton treatment planning with robust optimization and dose volume constraints | Vicki Taasti | ![]() |
![]() |
|||
PO-1439 | COMPARISON OF TWO ALGORITHMS FOR LEAVES MOTION CALCULATION IN ECLIPSE TREATMENT PLANNING SYSTEM | Alejandro Seoane | ![]() |
![]() |
|||
PO-1440 | Influence of heterogeneities on the dose calculation accuracy in proton beam therapy | Sirinya Ruangchan | ![]() |
![]() |
|||
PO-1441 | A novel, fast and accurate 3D-dose-based MLC segmentation for robotic radiotherapy | Bas Schipaanboord | ![]() |
![]() |
|||
PO-1443 | Brainlab spine SRS planning and verification, comparison with CyberKnife | Caroline Jones | ![]() |
![]() |
|||
PO-1444 | Robust optimization with accumulated dose over full treatment course reduces dose to organs at risk | Erik Engwall | ![]() |
![]() |
|||
PO-1445 | A feasibility study: can a vol/dose model in HNC standardize plans and optimize planning time? | Paolo Ferrari | ![]() |
![]() |
|||
PO-1448 | Fully-automated VMAT treatment planning: head to head between genetic and iterative algorithms | Christian Fiandra | ![]() |
![]() |
|||
PO-1449 | A robust optimization algorithm for brachytherapy | Xianliang Wang | ![]() |
![]() |
|||
PO-1450 | Analysis of breast radiotherapy plans generated by the EZFluence software | JUAN-FRANCISCO CALVO-ORTEGA | ![]() |
![]() |
|||
PO-1451 | Robotic MLC-based plans: a study of modulation complexity | Laura Masi | ![]() |
![]() |
|||
PO-1453 | Aperture shape controller tool impact assessment on the quality of arc therapy treatment plans | Izabela Tyburska | ![]() |
![]() |
|||
PO-1454 | Evaluation of two arc trajectory optimization algorithms for intracranial tumours VMAT planning | Tiago Ventura | ![]() |
![]() |
|||
PO-1455 | Evaluation of dosimetric changes during treatment with photons and protons for head and neck cancer | David Church | ![]() |
![]() |
|||
PO-1459 | Fully automated machine learning optimization VMAT planning for oropharyngeal cancer | Ilse van Bruggen | ![]() |
![]() |
|||
PO-1462 | Automated robust planning for IMPT in oropharyngeal cancer patients using machine learning | Merle Huiskes | ![]() |
![]() |
|||
PO-1464 | Total body irradiation practice in Australia and New Zealand: Results of a Survey | Lotte Fog | ![]() |
![]() |
|||
PO-1465 | Automated versus manual LINAC stereotactic radiosurgery plans in patients with 4-10 brain metastases | Anna Petoukhova | ![]() |
![]() |
|||
PO-1466 | Dosimetric comparison 3D vs VMAT tecniques in a pediatric population treated for Hodgkins Lymphoma | Simone Baroni | ![]() |
![]() |
|||
PO-1467 | Comparison of Planning Techniques in Randomised Radiotherapy Trials for Localised Prostate Cancer | Ian Gleeson | ![]() |
![]() |
|||
PO-1469 | Personalized automated planning of prostate plans using geometrical ideal dose distribution | Martijn Kusters | ![]() |
![]() |
|||
PO-1470 | Personalized Planning for prostate radiotherapy in Pinnacle Evolution improves planning efficiency | martijn kusters | ![]() |
![]() |
|||
PO-1471 | Dosimetric comparison of neoadjuvant proton beam therapy vs VMAT in distal oesophageal cancer using cases from the UK NeoSCOPE Trial | Owen Nicholas | ![]() |
![]() |
|||
PO-1472 | Cardiac dose reduction in proton vs. photon DIBH breast and regional lymph nodes radiotherapy | Piotr Winczura | ![]() |
![]() |
|||
PO-1473 | On the clinical implementation of conformity index for radiotherapy of prostate | Jonas Scherman | ![]() |
![]() |
|||
PO-1474 | Automated VMAT-SBRT treatment planning for complex spinal metastases: a dosimetric analysis | Savino Cilla | ![]() |
![]() |
|||
PO-1475 | Patient ion for intensity-modulated proton therapy (IMPT) using automated treatment planning and machine learning | Jasper Kouwenberg | ![]() |
![]() |
|||
PO-1476 | Monte Carlo based 3D treatment planning using intraoperative CBCT scanning for image guided IORT | Luis Probst | ![]() |
![]() |
|||
PO-1477 | Comparison of 3D-CRT, IMRT and VMAT plans (including low body dose) for whole breast irradiation | Agnieszka Walewska | ![]() |
![]() |
|||
PO-1478 | The effect of magnetic port density on dose distribution in 3D, IMRT, VMAT for breast radiotherapy | Agnieszka Walewska | ![]() |
![]() |
|||
PO-1479 | OARs dose volume parameters temporal evolution in Breast Cancer RT treatment in a single institution | MARIA LIZONDO | ![]() |
![]() |
|||
PO-1480 | Position in breast cancer radiotherapy: dosimetry and toxicity | DAVID HERNANDEZ | ![]() |
![]() |
|||
PO-1481 | A recommendation for density overrides in lung SBRT through model theory | Santiago Velázquez | ![]() |
![]() |
|||
PO-1482 | Feasibility of 3D-printed electron-modulated bolus for post lumpectomy left breast cancer patients | Wan Yan Venus Lee | ![]() |
![]() |
|||
PO-1483 | Evaluation of an artificial intelligence driven planning system for online adaptive radiotherapy | lucie Calmels | ![]() |
![]() |
|||
PO-1485 | Comparison of electron beam shaping efficiency with metal and 3D-printed plastic collimators | Sergei Stuchebrov | ![]() |
![]() |
|||
PO-1486 | Electron beam depth dose distributions in 3D-printed samples with different material filling factor | Sergei Stuchebrov | ![]() |
![]() |
|||
PO-1487 | Proton versus photon therapy in locally advanced cervical cancer; a dosimetric study | Danya Abdulwahid | ![]() |
![]() |
|||
PO-1488 | Emerging method of beam shaper with high density silicone bolus for electron beam radiotherapy | Santiago Velázquez Miranda | ![]() |
![]() |
|||
PO-1490 | Lung degradation effects on RBE-weighted dose in proton, carbon and helium treatment plans | Noa Homolka | ![]() |
![]() |
|||
PO-1491 | What is best practice for using a mixed technique concept for hypofractionated RT of breast cancer? | Alexander Venjakob | ![]() |
![]() |
|||
PO-1492 | VMAT modalities scenarios in ESTRO-ACROP consensus guidelines postmastectomy implants radiotherapy | Grazia Lazzari | ![]() |
![]() |
|||
PO-1493 | VMAT half-body palliative irradiation in widespread complex pelvic bone metastatic cancers | Grazia Lazzari | ![]() |
![]() |
|||
PO-1494 | Dose integration method of intensity-modulated arc therapy and HDR brachytherapy of prostate cancer | Georgina Frhlich | ![]() |
![]() |
|||
PO-1496 | Internal dose-escalation with FFF-VMAT and advantages in SRS metastasis treatments | Maria Jose Perez Calatayud | ![]() |
![]() |
|||
PO-1497 | Small cone vs microMLC in SRS trigeminal neuralgia: Dosimetric improvement. | Maria Jose Perez Calatayud | ![]() |
![]() |
|||
PO-1498 | Dosimetric analysis of the use of FFF beams with SBRT for lung cancer | Eleonor Rivin del Campo | ![]() |
![]() |
|||
PO-1499 | Incidental dose to obturator nodes in prostate radiotherapy trials CHHiP, PROFIT and PIVOTALboost | IAN GLEESON | ![]() |
![]() |
|||
PO-1501 | Frameless workflow for radiosurgery of arteriovenous malformations - A new software prototype | Daniel Schmidhalter | ![]() |
![]() |
|||
PO-1502 | A comparison of photon and proton radiotherapy treatment planning techniques in head and neck cancer | David Church | ![]() |
![]() |
|||
PO-1503 | Evaluation of a generalized knowledge-based planning for VMAT irradiation of breast and lymph nodes | Maria Rago | ![]() |
![]() |
|||
PO-1504 | Pareto navigation guided automated planning: is a single patient enough to calibrate a solution? | Iona Foster | ![]() |
![]() |
|||
PO-1508 | Exploration of deformable image registration to augment training data for deep learning contouring | Rachel Baggs | ![]() |
![]() |
|||
PO-1509 | Application of RapidPlan in the optimization of planning for patients with prostate cancer | Maciej Raczkowski | ![]() |
![]() |
|||
PO-1510 | Cardiopulmonary Sparing During Breast RT with Personalized Breast Holder and Proton Beam Therapy | Renyi Wang | ![]() |
![]() |
|||
PO-1511 | Automatic treatment planning for left sided breast cancer with lymph nodes. | Kenni Engstroem | ![]() |
![]() |
|||
PO-1512 | VMAT based TBI using a novel rotatable tabletop | Christoph Losert | ![]() |
![]() |
|||
PO-1513 | Overdose areas in whole brain irradiation with simultaneous integrated boost and hippocampal sparing | ALESSIO PIERELLI | ![]() |
![]() |
|||
PO-1514 | NON-COPLANAR TRAJECTORY VMAT FOR TREATMENT OF SPINAL METASTATIC TUMORS | Janita van Timmeren | ![]() |
![]() |
|||
PO-1517 | Development and validation of a 3D dose calculation software for neutron radiotherapy | Lucas Sommer | ![]() |
![]() |
|||
PO-1521 | Endorectal balloon air filling for extreme hypofractionated prostate SBRT | Sandra Vieira | ![]() |
![]() |
|||
PO-1522 | 3D vs 4D dose calculations for moving target near air cavity for lung VMAT SBRT planning | Yassir Almutairi | ![]() |
![]() |
|||
PO-1523 | Predictive factors of over Grade 2 radiation pneumonitis for advanced non-small cell lung cancer. | KOICHIRO MURAKI | ![]() |
![]() |
|||
PO-1524 | FET-PET radiomics predicting outcome after re-irradiation in recurrent glioblastoma | Ilinca Popp | ![]() |
![]() |
|||
PO-1528 | Predicting response to neoadjuvant chemoradiation in esophageal cancer using CT radiomic features | Indranil Mallick | ![]() |
![]() |
|||
PO-1530 | Pulmonary toxicity in lung cancer treated by (chemo)-radiotherapy : a radiomics-based NTCP. | Vincent Bourbonne | ![]() |
![]() |
|||
PO-1533 | Feature ion methods improve accuracy in radiation toxicity prediction for lung cancer | Jose Luis Lopez Guerra | ![]() |
![]() |
|||
PO-1534 | Tumour response modelling to radiochemotherapy with gemcitabine for pancreatic cancer | Brigida Costa Ferreira | ![]() |
![]() |
|||
PO-1536 | RadiomiK: a phantom to test repeatability and reproducibility of CT-derived Radiomic Features | Stefania Pallotta | ![]() |
![]() |
|||
PO-1537 | Robustness analysis of standardized radiomic features extracted from T2-weighted MR images | Concetta Piazzese | ![]() |
![]() |
|||
PO-1539 | Predictive modelling of late fibrosis in breast cancer radiotherapy | MARIA LIZONDO | ![]() |
![]() |
|||
PO-1540 | Radiomic models for validation in patients with locally advanced HNSCC treated with primary RTCx | Asier Rabasco Meneghetti | ![]() |
![]() |
|||
PO-1541 | Predictive treatment planning with SIP (simultaneously integrated protection) based on TCP and NTCP | Benedikt Thomann | ![]() |
![]() |
|||
PO-1542 | Integrating biomarker performance in sample size calculations for therapeutic trials | Cary Oberije | ![]() |
![]() |
|||
PO-1543 | Public radiomics data collections in an open access Semantic Web (SPARQL) endpoint | Petros Kalendralis | ![]() |
![]() |
|||
PO-1545 | Dose-volume factors predicting esophageal after SBRT for ultra-central lung tumors | Abraham Wu | ![]() |
![]() |
|||
PO-1546 | KRAS mutation prediction of mCRC patients based on pre-treatment liver metastasis MRI images | Wei Zou | ![]() |
![]() |
|||
PO-1547 | Prediction of late subcutaneous fibrosis after partial breast irradiation by radiomics and dosiomics | Michele Avanzo | ![]() |
![]() |
|||
PO-1550 | Radiomics characteristics correlate with immune activation and HPV status in head and neck cancer | Jung Hun Oh | ![]() |
![]() |
|||
PO-1552 | Modelling the increase in local control seen when employing synchronous chemo and IMRT in NPC as BED | Alfred Mel | ![]() |
![]() |
|||
PO-1553 | Development of a CT based radiomic model predictive of non-response to induction chemotherapy in laryngeal cancers | Ingrid Masson | ![]() |
![]() |
|||
PO-1554 | Radiogenomics: A Virtual Biopsy in Non-small Cell Lung Cancer? | Helen Saxby | ![]() |
![]() |
|||
PO-1556 | 4D-PET radiomics-features for radiotherapy treatment monitoring in locally advanced NSCLC patients | Montserrat Carles | ![]() |
![]() |
|||
PO-1558 | Model based target definition for high-grade gliomas: implementation and sensitivity analysis | Wille Hger | ![]() |
![]() |
|||
PO-1559 | Survival prediction in GBM using radiomics of multimodal imaging | Fatima TENSAOUTI | ![]() |
![]() |
|||
PO-1561 | Staging of non-small cell lung cancer using random forest classifiers based on radiomics | Souha Aouadi | ![]() |
![]() |
|||
PO-1562 | Radiomics applied to dose distributions to predict toxicity after radiotherapy in cervical cancer | Franois Lucia | ![]() |
![]() |
|||
PO-1563 | New voxel-based approach to study the relation of tumor location and survival in NSCLC (SAKK-16/00) | Diem Vuong | ![]() |
![]() |
|||
PO-1564 | Influence of inter-observer delineation variability on radiomics features of the parotid gland | Elizabeth Forde | ![]() |
![]() |
|||
PO-1566 | NTCP modeling for radiation induced optic neuropathy in a high-risk proton therapy patient cohort | Andreas Kthe | ![]() |
![]() |
|||
PO-1568 | The Impact of Varying Number of OSEM Subsets on PET Radiomic Features: A Preclinical Study | EMAD ALSYED | ![]() |
![]() |
|||
PO-1569 | Early prediction of tumour-response to radiotherapy in NSCLC patients. | Lameck Mbangula Amugongo | ![]() |
![]() |
|||
PO-1570 | Robustness of dosomic features extraction on grid resolution and algorithm model calculation | Lorenzo Placidi | ![]() |
![]() |
|||
PO-1571 | Radiomics for prediction of metastatic melanoma patient survival after immunotherapy | Hubert Gabrys | ![]() |
![]() |
|||
PO-1572 | Use of intravoxel incoherent motion (IVIM) MRI for predicting dysphagia in oropharyngeal carcinoma | Marta Maddalo | ![]() |
![]() |
|||
PO-1574 | Robustness of CT-based prostate radiomics features against artefacts from gold fiducial markers | Sarah Osman | ![]() |
![]() |
|||
PO-1575 | Predicting doses to organs-at-risk in prostate cancer intensity modulated radiotherapy | Indranil Mallick | ![]() |
![]() |
|||
PO-1576 | Assessment of mpMRI-based radiomics tools in PCa for cancer aggressiveness prediction, AIRC IG-13218 | Matteo Pepa | ![]() |
![]() |
|||
PO-1578 | Heart V10 is related to treatment-elicited inflammation and clinical response in esophageal cancer. | Yu-Chieh Ho | ![]() |
![]() |
|||
PO-1580 | CBCT-Based Radiomics of Prostate Cancer | Nesrin Dogan | ![]() |
![]() |
|||
PO-1582 | Dose rate effects in robotic radiosurgery treatments | Emmanouil Zoros | ![]() |
![]() |
|||
PO-1584 | Predicting xerostomia in head and neck cancer using imaging biomarkers from daily tomotherapy MVCTs | Thomas Berger | ![]() |
![]() |
|||
PO-1585 | Subregional analysis of the parotid glands: predicting late xerostomia in head and neck cancer | Thomas Berger | ![]() |
![]() |
|||
PO-1587 | Novel biocompatible artifact-robust and highly visible fiducial marker for image-guided radiotherapy | Tianyuan Wang | ![]() |
![]() |
|||
PO-1588 | Effect of breathing motion on robustness of locoregional proton plans for left-sided breast cancer | Anna Petoukhova | ![]() |
![]() |
|||
PO-1589 | Comparison of diaphragm motion amplitude during free versus regularized breathing measured with MRI | Zdenko van Kesteren | ![]() |
![]() |
|||
PO-1590 | Spirometer guided breathhold breast VMAT on Halcyon verified with portal images and surface tracking | Laurence Delombaerde | ![]() |
![]() |
|||
PO-1592 | Effect of respiratory motion on lung target volume during 4D-CT and 4D-CBCT imaging | JINYI LANG | ![]() |
![]() |
|||
PO-1593 | Impact of left ventricular V5 on acute coronary event cumulative risk in breath-hold breast IMRT | Savino Cilla | ![]() |
![]() |
|||
PO-1594 | Impact of mean heart dose on acute coronary event excess cumulative risk in breath-hold breast IMRT | Savino Cilla | ![]() |
![]() |
|||
PO-1595 | MR guided tumour tracking on a high field MR Linac: feasibility and first experimental results | Simeon Nill | ![]() |
![]() |
|||
PO-1596 | End-to-end test in MRgRT: 3D dose verification of a gated treatment with a porcine lung phantom | Philipp Mann | ![]() |
![]() |
|||
PO-1597 | Identifying inconsistent breathing patterns for increased monitoring during breath-hold treatment | Tomi Nano | ![]() |
![]() |
|||
PO-1598 | Investigating the use of RayPilot for motion management during prostate SBRT: initial experience | Michael Trainer | ![]() |
![]() |
|||
PO-1600 | Evaluation of a High Dynamic Multileaf Collimator for Real-Time tumor tracking | Carlos Murillo | ![]() |
![]() |
|||
PO-1601 | electromagnetic localization and tracking for prostate cancer radiotherapy: impact of hip prostheses | marta bottero | ![]() |
![]() |
|||
PO-1602 | Great vessel motion mapping from 4D MRI to 3D CT - Implications for Oligometastatic spinal SBRT | Bhavya Patneedi | ![]() |
![]() |
|||
PO-1603 | Residual intra-fraction error in tracked spinal SBRT: effect of site, fractionation and patient pain | Eleonora Rossi | ![]() |
![]() |
|||
PO-1604 | Quantitative analysis of treatment process time for MRI-LINAC system gating efficiency optimization | Lorenzo Placidi | ![]() |
![]() |
|||
PO-1605 | Can we ignore rotational errors in the positioning of patients with high-risk prostate cancer? | Maria Poncyljusz | ![]() |
![]() |
|||
PO-1607 | Development of a Robot Assisted Ultrasound Based Radiation Therapy (USgRT) | Peter Karl Seitz | ![]() |
![]() |
|||
PO-1608 | Assessment of shoulder position variation and its impact on VMAT doses using an EPID-based software | Itziar Valverde-Pascual | ![]() |
![]() |
|||
PO-1609 | DOSIMETRIC EFFECT OF INTRAFRACTION MOTION ON HYPOFRACTIONATED PROSTATE RADIATION THERAPY PLANS | Maria Roch | ![]() |
![]() |
|||
PO-1612 | Bladder filling during MR-linac treatment sessions. | Mariska den Hartogh | ![]() |
![]() |
|||
PO-1615 | Detection and analysis of scattered protons for verification of FLASH lung tumor proton therapy | Magdalena Garbacz | ![]() |
![]() |
|||
PO-1617 | Feasibility of spirometer-guided single breath-hold kV-CBCTs on Halcyon in lung cancer patients | Laurence Delombaerde | ![]() |
![]() |
|||
PO-1619 | Detailed study of accuracy and potential improvements of surface-guided breast cancer radiotherapy | Saber Nankali | ![]() |
![]() |
|||
PO-1620 | Reconstruction of intra-fractional prostate movement and its effect on dose distribution | Lauri Jrvinen | ![]() |
![]() |
|||
PO-1621 | Surface Guided Radiotherapy for locoregional DIBH treatment: Intrafraction motion evaluation | Alessio Gnerucci | ![]() |
![]() |
|||
PO-1622 | Impact of positioning errors in the dosimetry of VMAT left-sided post mastectomy irradiation | QIAN PENG | ![]() |
![]() |
|||
PO-1624 | Fast contour propagation for MR-guided prostate radiotherapy using convolutional networks | Matteo Maspero | ![]() |
![]() |
|||
PO-1625 | Deformable image registration (DIR) and radiobiological recalculation for retreat plan evaluation | Laura Stenzel | ![]() |
![]() |
|||
PO-1627 | Evaluation of Tumor Volume and Electron Density Changes on CBCT Images in Lung Cancer Patients | Esil Kara | ![]() |
![]() |
|||
PO-1628 | Deconvolution of different range error sources using proton radiography and neural networks | Carmen Seller Oria | ![]() |
![]() |
|||
PO-1629 | A quantitative evaluation of deformable image registration based on Halcyon MVCBCT images | Yuliang Huang | ![]() |
![]() |
|||
PO-1630 | Accurate 3D-rotation correction for stereotactic intracranial treatments without a 6D couch | Stefan L.S. Kwa | ![]() |
![]() |
|||
PO-1631 | Potential benefit of robust ITV-based proton therapy in cervical cancer patients | Elske Marjolein Gort | ![]() |
![]() |
|||
PO-1632 | Planning target volume (PTV) reduction for gated stereotactic body radiotherapy(SBRT) of lung tumors | Kim Kraus | ![]() |
![]() |
|||
PO-1636 | Robustness of breast treatments with Tomotherapy toward residual setup errors | Livia Marrazzo | ![]() |
![]() |
|||
PO-1637 | Proton therapy for patients with head and neck cancer: A strategy for adaptation | Eva Samse | ![]() |
![]() |
|||
PO-1638 | Treatment delivery uncertainties in rectal cancer radiotherapy evidence-based margin estimates | Ane Appelt | ![]() |
![]() |
|||
PO-1640 | DOSIMETRIC IMPACT OF RECTUM AND BLADDER ANATOMY DURING HYPOFRACTIONATED PROSTATE RADIATION THERAPY | Maria Roch | ![]() |
![]() |
|||
PO-1641 | Role of surface imaging for verification of mono-isocentric multi-focal stereotactic radiosurgery | Daniel Saenz | ![]() |
![]() |
|||
PO-1642 | CBCT Padding for Full Field of View Daily Dose Accumulation and Head and Neck Adaptive Radiotherapy | Kristy Brock | ![]() |
![]() |
|||
PO-1643 | Factors associated with image guided radiation therapy image rejection in a multi-site institution | Gary Walker | ![]() |
![]() |
|||
PO-1644 | Inter-session variability of 4DMRI image quality after outlier rejection | Johannes Veldman | ![]() |
![]() |
|||
PO-1645 | Development of protocol for EPID IVD based adaptive radiotherapy in a small RT unit. | Patrycja Borowska | ![]() |
![]() |
|||
PO-1647 | Quantifying the dose accumulation uncertainty after DIR in head-and-neck radiotherapy | Nicholas Lowther | ![]() |
![]() |
|||
PO-1648 | Impact of image deformation workflow in high-field MR-Linac treatment of head and neck cancer | Rasmus Christiansen | ![]() |
![]() |
|||
PO-1649 | Dose comparison between hybrid plan and deformable images plan using extended computed tomography scan in nasopharyngeal cancer patients | Wasin Iabsakul | ![]() |
![]() |
|||
PO-1650 | Evaluating plan robustness for organ deformation and set-up uncertainties in head and neck cancer | Jennifer Robbins | ![]() |
![]() |
|||
PO-1651 | Inter and intra-fractional stability of rectal gas in cervical cancer patients | Jane Shortall | ![]() |
![]() |
|||
PO-1652 | In silico trial of cone-beam-CT guided adaptive planning for radiotherapy of locally advanced NSCLC | Philipp Hoegen | ![]() |
![]() |
|||
PO-1653 | Dosimetric effects of interfractional variations in prostate cancer radiotherapy | Tilman Bostel | ![]() |
![]() |
|||
PO-1654 | Markerless liver stereotactic body radiotherapy on a 1.5 T MR-Linac | Sihan Gani | ![]() |
![]() |
|||
PO-1655 | Dosimetric impact of the anatomical pelvic organs variations during prostate cancer IMRT | Fatma Dhouib Trabelsi | ![]() |
![]() |
|||
PO-1656 | Plan library to manage daily motion in locally advanced cervical cancer | Zelda Paquier | ![]() |
![]() |
|||
PO-1659 | Importance of rotational setup errors in H&N patients treated with IMRT | Mihály Simon | ![]() |
![]() |
|||
PO-1661 | Treatment setup errors in cranial SRT patients with non-invasive immobilization technique | Mihály Simon | ![]() |
![]() |
|||
PO-1662 | Influence of ITV-PTV margins on interfraction dosimetric variations in lung SBRT. | Ana Garcia Perez | ![]() |
![]() |
|||
PO-1664 | Standard robust optimization of IMPT for nasopharyngeal cancer covers anatomical changes | Raul Argota Perez | ![]() |
![]() |
|||
PO-1665 | The mesorectum motion using MR-guided Radiotherapy: an exploratory study to quantify PTV margins | Angela Romano | ![]() |
![]() |
|||
PO-1666 | Comparison of dose accumulation based on CBCT and CT for lung cancer patients | Takahiro Kanehira | ![]() |
![]() |
|||
PO-1667 | Are current margins in locally advanced cervical cancers treated by tomotherapy appropriate? | Stephane Niyoteka | ![]() |
![]() |
|||
PO-1668 | Can we use cascade deep learning for GTV delineation in adaptive radiotherapy for NPC? | Nejla Fourati | ![]() |
![]() |
|||
PO-1669 | Novel fiducial marker has optimal characteristics for image-guided radiotherapy of abdominal tumours | Sarah Stefanowicz | ![]() |
![]() |
|||
PO-1670 | Dosimetric and Volumetric impact of Intensity Modulated Adaptive Radiotherapy in Head Neck Cancer | Swarupa Mitra | ![]() |
![]() |
|||
PO-1674 | The optimal tradeoff between scan time and parameter precision for NG-IVIM DWI for H&N cancer | Nienke Sijtsema | ![]() |
![]() |
|||
PO-1675 | Diffusion-weighted MRI to evaluate irradiated parotid function: a study of acute and late morbidity | Ahmad Ameri | ![]() |
![]() |
|||
PO-1676 | Blood biomarkers for cognitive damage after PCI; an exploratory analysis of the HA-PCI phase 3 trial | Inge Compter | ![]() |
![]() |
|||
PO-1677 | Quality Volume Histogram concept for personalized radioembolization based on MAA SPECT-CT simulation | Manuela Burghelea | ![]() |
![]() |
|||
PO-1678 | Prostate tumor characteristics in acetate-PET and MRI - Impact of androgen depravation therapy. | Ulrika Bjreland | ![]() |
![]() |
|||
PO-1679 | Tumor volume regression during neoadjuvant chemoradiotherapy for esophageal cancer: a prospective study with weekly MRI | Ingmar Defize | ![]() |
![]() |
|||
PO-1680 | DW-MRI of parotid glands in head and neck cancer patients treated with radiotherapy | Maja Bruvo | ![]() |
![]() |
|||
PO-1682 | MR-based adaptive IGRT for prostate cancer: Results of an exploratory cohort on DWI | Arndt-Christian Mller | ![]() |
![]() |
|||
PO-1684 | Serial MRI assessment of salivary glands in patients with Oropharyngeal SCC receiving radical RT | Claire Paterson | ![]() |
![]() |
|||
PO-1685 | Serial DWI in HNC treated on a 1.5 T MR-Linac and benchmark to a reference 3 T diagnostic MR-scanner | Simon Boeke | ![]() |
![]() |
|||
PO-1686 | Electron density and effective atomic number estimation in a maximum a posteriori framework for DECT | Mikael Simard | ![]() |
![]() |
|||
PO-1687 | Regional lung motion amplitude and variability assessment from a 4DMRI dataset | Emma Colvill | ![]() |
![]() |
|||
PO-1689 | TCP assessment of PET-derived dose prescriptions accounting for the underlying oxygen distribution | Ana Ureba | ![]() |
![]() |
|||
PO-1690 | SUVmax and tumor size in 18 F PET-CT as predictors for early response after lung SBRT | Daniela GONSALVES | ![]() |
![]() |
|||
PO-1692 | A novel approach to proton radiography and CT using a large-volume scintillator detector system | Chinmay Darne | ![]() |
![]() |
|||
PO-1693 | Correlation between SUVmax and Primary Tumor Volume in Cervical Cancer Received Radiation Therapy | SEOK HO LEE | ![]() |
![]() |
|||
PO-1694 | PET/MR hybrid imaging in correlation with p16, HPV and EBV presence in head and neck cancer patients | Natalia Samolyk-Kogaczewska | ![]() |
![]() |
|||
PO-1696 | Quantitative analysis of mean ADC in cervix cancer patients during chemoradiotherapy | Anubhav Datta | ![]() |
![]() |
|||
PO-1697 | Radiotherapy for prostate cancer: Effects of fiducial gold marker on diffusion-weighted MR imaging | Osamu Tanaka | ![]() |
![]() |
|||
PO-1698 | Deep learning-based sCTs with uncertainty estimation from heterogeneous pediatric brain MRI | Matteo Maspero | ![]() |
![]() |
|||
PO-1699 | Clinical implementation of MRI-based prostate OARs auto-segmentation with convolutional networks | Matteo Maspero | ![]() |
![]() |
|||
PO-1700 | Efficacy evaluation of 2-D and 3-D U-Net semantic segmentation of normal lungs | Takafumi Nemoto | ![]() |
![]() |
|||
PO-1701 | Optimized source-detector trajectories for low dose CBCT | Sepideh Hatamikia | ![]() |
![]() |
|||
PO-1702 | Optimizing the generation of brain pseudo-CT from MRI based on a highly efficient 3D neural network | Emilie Alvarez Andres | ![]() |
![]() |
|||
PO-1703 | Renal positional probability mapping using ultra-fast volumetric 4D-MRI for MRgRT | Oi Lei Wong | ![]() |
![]() |
|||
PO-1704 | Global and local evaluation of deep learning contouring of prostate CT | Ellen Brunenberg | ![]() |
![]() |
|||
PO-1706 | Low dose fluence-modulated proton CT: simulation study and first experimental results | Jannis Dickmann | ![]() |
![]() |
|||
PO-1707 | Fibroblast Activation Protein (FAPI) PET for diagnostics and advanced target volume delineation in head and neck cancer | Mustafa Syed | ![]() |
![]() |
|||
PO-1708 | Retrospective automatic detection of calcified plaque in heart on planning CT:viability and benefits | MARIA LIZONDO | ![]() |
![]() |
|||
PO-1709 | Automated organ delineation in T2 head MRI using combined 2D and 3D convolutional neural networks | Laszlo Rusko | ![]() |
![]() |
|||
PO-1711 | A CBCT based quality assurance technique for an MR-only radiotherapy workflow for head patients | Sinan Irmak | ![]() |
![]() |
|||
PO-1712 | Dosimetric Impact of MRI inaccuracy in SBRT in the presence of motion: digital phantom study | Tarraf Torfeh | ![]() |
![]() |
|||
PO-1713 | An iterative approach to reduce noise in dual-energy CT (DECT) for radiotherapy treatment planning | Jens Zimmerman | ![]() |
![]() |
|||
PO-1714 | Multimodalities imaging PET/CT-MR for radiotherapy: study of positioning uncertainties | Pauline Hinault | ![]() |
![]() |
|||
PO-1715 | Predicting dosimetric impact of (auto)contouring errors before dose planning in VMAT prostate radiotherapy. | Daniel Sandys | ![]() |
![]() |
|||
PO-1716 | Histology correlation of in-vivo 68GaPSMA-PET/MRI: A method description and uncertainty estimation | Kristina Sandgren | ![]() |
![]() |
|||
PO-1717 | 4D-segmentation-based anatomy-restricted motion-compensated reconstruction of on-board 4D CBCT scans | Markus Susenburger | ![]() |
![]() |
|||
PO-1718 | Deep learning based auto-contouring of planning CT scans for rectal cancer | Leonard Bokhorst | ![]() |
![]() |
|||
PO-1719 | Clinical evaluation of deep learning auto-contouring in prostate and head and neck cancer. | Christina Hague | ![]() |
![]() |
|||
PO-1720 | Evaluation of the compatibility and accuracy of lung tumor ITV between 4D-CT and 4D-CBCT MIP images | Yulun Tseng | ![]() |
![]() |
|||
PO-1721 | A voxel-based method to quantify longitudinal MRI changes after pediatric brain irradiation. | Laura Toussaint | ![]() |
![]() |
|||
PO-1722 | AI-driven quality assurance for delineation in radiotherapy breast clinical trials | Sofia RIVERA | ![]() |
![]() |
|||
PO-1723 | Evaluation of outlier rejection in 4D-MRI for motion estimation of subsequent sessions | Duncan den Boer | ![]() |
![]() |
|||
PO-1724 | Intelligent 4D CT sequence scanning (i4DCT): First prototype measurements | Rene Werner | ![]() |
![]() |
|||
PO-1725 | Evaluation of measures for assessing automatic OAR delineation acceptability and time-savings | Femke Vaassen | ![]() |
![]() |
|||
PO-1726 | Clinical impact of spectral CT-based stopping power prediction for particle therapy planning | Friderike Faller | ![]() |
![]() |
|||
PO-1727 | The geometric and dosimetric effect of algorithm choice on propagated contours from CT to CBCTs | David Masj | ![]() |
![]() |
|||
PO-1729 | Quality assurance of deformable image registration for bowel motility quantification | Koen Nelissen | ![]() |
![]() |
|||
PO-1730 | Development of a framework to quantify bowel motility in 3D using MRI | Danique Barten | ![]() |
![]() |
|||
PO-1731 | Deep learning based conversion of CBCT to synthetic CT for prostate radiotherapy | Paolo Zaffino | ![]() |
![]() |
|||
PO-1732 | Feasibility of virtual dual-energy imaging through deep learning for markerless tumour tracking | Sebastian Amador Sanchez | ![]() |
![]() |
|||
PO-1733 | Validation of PSMA-PET/CT based contouring techniques for intraprostatic tumor definition | Dejan Kostyszyn | ![]() |
![]() |
|||
PO-1734 | Assessment of extended field-of-view CT reconstructions for radiotherapy | Gabriel Fonseca | ![]() |
![]() |
|||
PO-1735 | Superparamagnetic nickel ferrite nanoparticles as contrast agents in Magnetic Resonance Imaging | Carlos Ferrer | ![]() |
![]() |
|||
PO-1736 | High frame rate CAIPIRINHA-TWIST-VIBE MRI for volumetric motion monitoring in MRgRT: a pilot study | Wong Oi Lei | ![]() |
![]() |
|||
PO-1738 | Dosimetric evaluation of deep learning generated synthetic CT data for H&N MRI only radiotherapy | Emilia Palmér | ![]() |
![]() |
|||
PO-1739 | A deep learning neural network to remove metal artefacts via residual learning for cone-beam CT | Mikkel Skaarup | ![]() |
![]() |
|||
PO-1740 | Quantitative evaluation of ultra-low dose paediatric cone beam CT for image-guided radiotherapy | Abigail Bryce-Atkinson | ![]() |
![]() |
|||
PO-1741 | Evaluation of atlas and deep learning based automatic contouring A spatially resolved approach | Isabell Steinseifer | ![]() |
![]() |
|||
PO-1745 | PET/MRI for RT planning: CT-based attenuation correction of radiation treatment positioning devices | Clarissa Gillmann | ![]() |
![]() |
|||
PO-1746 | Deep learning artificial intelligence for auto-segmentation of the bowel bag. | Jack Miskell | ![]() |
![]() |
|||
PO-1747 | Segmentation of the Heart using a Residual U-Net model | Miguel Garrett Fernandes | ![]() |
![]() |
|||
PO-1748 | Carbon-ion boost followed by photon IMRT for PCa: dosimetric and geometric evaluations, AIRC-IG14300 | Giulia Marvaso | ![]() |
![]() |
|||
PO-1749 | Contour propagation using Velocity deformable image registration for re-scanned head & neck patients | Ryan Fullarton | ![]() |
![]() |
|||
PO-1751 | Effect of pseudoCT methods on dose-derived rectal toxicity prediction in MR-only prostate RT | Christopher Thomas | ![]() |
![]() |
|||
PO-1752 | Evaluation of the deformable image registration algorithm in Velocity image registration software | Ryan Fullarton | ![]() |
![]() |
|||
PO-1753 | Full-body delineation of ROIs through anatomy-preserving deep learning ensemble networks | Aurélien Lombard | ![]() |
![]() |
|||
PO-1755 | Use of Jigsaw puzzles to train convolutional neural networks for segmentation with limited data | Edward Henderson | ![]() |
![]() |
|||
PO-1756 | Phantom investigation of the geometric accuracy of 4D-CBCT | Valentina Giacometti | ![]() |
![]() |
|||
PO-1757 | Peer Review in Stereotactic Body Radiotherapy: The Impact of Case Volume | Michael Huo | ![]() |
![]() |
|||
PO-1758 | Performance studies of an MR linear accelerator using a 3D-printed ball-bearing phantom | Hans Lynggaard Riis | ![]() |
![]() |
|||
PO-1761 | A cross-platform daily QA of MRI simulator using an ACR MRI phantom | Oi Lei Wong | ![]() |
![]() |
|||
PO-1762 | Dummy Run for bone SBRT in french multicentric study | sebastien thureau | ![]() |
![]() |
|||
PO-1763 | Generation of artificial realistic MR and CT images using StyleGAN | Lukas Fetty | ![]() |
![]() |
|||
PO-1764 | Prognostic outcome prediction for head and neck cancer patients using convolutional neural networks | Jiapan Guo | ![]() |
![]() |
|||
PO-1765 | Treatment of face and scalp with HelicalTomotherapy: feasibility, robustness and dosimetric accuracy | Livia Marrazzo | ![]() |
![]() |
|||
PO-1766 | A clinical solution for electron streaming shielding for partial breast treatments on Unity MR-linac | Joan Chick | ![]() |
![]() |
|||
PO-1767 | A national survey of total body irradiation to define best practice for the ALL-RIC trial | Patricia Diez | ![]() |
![]() |
|||
PO-1769 | Multicenter end-to-end test for lung SBRT treatments | Stefania Pallotta | ![]() |
![]() |
|||
PO-1770 | Failure Modes and Effects Analysis with Lu-177 Dotatate PRRT in a Radiation Oncology-based Program | Nichole Maughan | ![]() |
![]() |
|||
PO-1771 | Significant lower dose to brain after implementation of new treatment protocol for brain metastasis | André Haraldsson | ![]() |
![]() |
|||
PO-1773 | A Comprehensive and feasible QA Program for Surface Guided Radiotherapy | Vania Batista | ![]() |
![]() |
|||
PO-1775 | Texture analysis of Tomotherapy planned sinograms to assess plans modulation | Tania Santos | ![]() |
![]() |
|||
PO-1778 | Analysis of treatment times with a Halcyon 2.0 linac | Marcelino Hermida López | ![]() |
![]() |
|||
PO-1781 | Development and implementation of an End-to-End test for small animals radiation research | Ileana Silvestre Patallo | ![]() |
![]() |
|||
PO-1782 | Compressed sense accelerated MRI simulation: image quality assessment using an ACR MRI phantom | Oi Lei Wong | ![]() |
![]() |
|||
PO-1783 | A method for performing film dosimetry as part of a postal audit service by a recalibration process | Burak Yalvac | ![]() |
![]() |
|||
PO-1784 | Quality Assurance for the adaptive workflow on an MRI Linac | Lotte Wilke | ![]() |
![]() |
|||
PO-1787 | Radiotherapy process management using InSightive: optimization, evaluation and verification | Maciej Raczkowski | ![]() |
![]() |
|||
PO-1788 | Automated data labeling in radiotherapy using a deep neural network | Pedro Gallego | ![]() |
![]() |
|||
PO-1790 | A 3D model of proton treatment rooms for collision prevention | Thomas Henry | ![]() |
![]() |
|||
PO-1792 | Electron beam aperture cut-out customization using 3D printed ABS plastic | ALEJANDRO SÁNCHEZ | ![]() |
![]() |
|||
PO-1793 | BioXmark liquid fiducials to enable radiotherapy tumor boosting in rectal cancer feasibility trial | Maaike Berbee | ![]() |
![]() |
|||
PO-1794 | Real-life experiences of an MR-Only prostate radiotherapy pathway with MR-CBCT soft-tissue matching | Hazel McCallum | ![]() |
![]() |
|||
PO-1795 | Clinical Validation of an AI software to auto segment OARs on CT datasets for Radiation Oncology | Chandrasekhar Kota | ![]() |
![]() |
|||
PO-1796 | Framework for Competency and Performance Assessment in Radiation Oncology: MRIdian Linac Case Study | Chandrasekhar Kota | ![]() |
![]() |
|||
PO-1797 | Dosimetric analysis of simultaneous integrated boost in the HYPORT Adjuvant Trial (NCT03788213) | SUBECHA BHUSAL | ![]() |
![]() |
|||
PO-1798 | Quality of radiotherapy treatment plans for locally advanced sinonasal tumors in a phase II trial | Barbara Vischioni | ![]() |
![]() |
|||
PO-1799 | The quality improvement in prostate radiotherapy based on results from end-to-end national audits | Irena Koniarova | ![]() |
![]() |
|||
PO-1800 | Successful Implementation of Treatment Planning Trial QA for the PIVOTALboost Trial | Helen Mayles | ![]() |
![]() |
|||
PO-1801 | A new standardized global plan complexity score indicator | Tania Santos | ![]() |
![]() |
|||
PO-1803 | Preventing Radioinduced Injury by Topical Application of an Amifostine Metabolite-Loaded Thermogel | Céline Clémenson | ![]() |
![]() |
|||
PO-1804 | In silico model of radiation-therapy damage to microvasculature of tissues surrounding tumour | alessandro cicchetti | ![]() |
![]() |
|||
PO-1806 | Early radio-induced bladder wall thickening in rats: optimizing the methodology and first evidences | Antonello Spinelli | ![]() |
![]() |
|||
PO-1807 | A multicenter assessment of HSPB1 and TGB1 SNPs for hematological toxicity in lung cancer patients | OSCAR MUÑOZ MUÑOZ | ![]() |
![]() |
|||
PO-1808 | Effects of photon, carbon ion and ultraviolet radiation on human mesenchymal stem cells | Alexander Rhle | ![]() |
![]() |
|||
PO-1809 | Parallel quantification of MR signal and radioenhancement of Gd nanoparticles for MR-based dosimetry | Pauline MAURY | ![]() |
![]() |
|||
PO-1810 | Determining the boundaries of the FLASH effect and delivering with proton spot scanning | Bethany Rothwell | ![]() |
![]() |
|||
PO-1811 | The prognostic value of CD8 infiltration and PD-L1 expression in salivary gland cancer | Jens von der Grn | ![]() |
![]() |
|||
PO-1813 | Plasma biomarkers of immunogenic cell death during and after SBRT and concurrent chemo-RT for NSCLC. | Kobe Reynders | ![]() |
![]() |
|||
PO-1815 | Dual oxidase 1 limits the IFN&947;-associated antitumor effect of macrophages | Meziani Lydia | ![]() |
![]() |
|||
PO-1816 | Impact of radiotherapy in immunological parameters in brain metastases by SRS | Antonio Lopez | ![]() |
![]() |
|||
PO-1817 | Kinetics and dose-volume effect of radiotherapy on leucocyte and platelet blood cell components | Cynthia Terrones Campos | ![]() |
![]() |
|||
PO-1818 | Cytogenetic and immunological markers to predict side effects and tumour control in cancer patients | Zsolt Juranyi | ![]() |
![]() |
|||
PO-1819 | Leukocyte migration towards particle radiation-induced senescence-associated secretory phenotypes | Peter Huber | ![]() |
![]() |
|||
PO-1821 | Investigating tumour immune microenvironment effects of hypofractionated radiotherapy /- immune checkpoint blockade in immunocompetent pre-clinical prostate cancer models | Yiannis Philippou | ![]() |
![]() |
|||
PO-1822 | PET-CT based metabolic regression velocity following SBRT for spinal oligometstases | Hirak Vyas | ![]() |
![]() |
|||
PO-1823 | New insights into cellular dose-response in vitro from high-throughput time-course assays | Robin Koch | ![]() |
![]() |
|||
PO-1824 | Superparamagnetic iron oxide nanoparticles as radiosensitisers with magnetic fields. | Emily Russell | ![]() |
![]() |
|||
PO-1825 | Determining the role of Abiraterone and Enzalutamide on radiosensitisation and DNA repair in response to ionising radiation and Radium-223 | Timothy Wright | ![]() |
![]() |
|||
PO-1826 | Measuring probability of double-strand breaks along a 160 MeV Bragg curve | Kristen McConnell | ![]() |
![]() |
|||
PO-1827 | Clinical application of radiation-enhancing nanoparticles | Nathaniel Scher | ![]() |
![]() |
|||
PO-1828 | Alignment of prostate cancer patients for radiotherapy on the MR-linac | Helen Barnes | ![]() |
![]() |
|||
PO-1829 | Can empty bladder filling protocol be implemented for localised prostate external beam radiotherapy? | Gayan Chetiyawardana | ![]() |
![]() |
|||
PO-1830 | Clinical verification of the pitch functionality and setup accuracy of the Solstice SRS System | Chin Loon Ong | ![]() |
![]() |
|||
PO-1831 | IV CONTRAST MEDIA IN RADIOTHERAPY PLANNING CT SCANS - CURRENT PRACTICE AND LEARNING IN IRELAND | Laura Mullaney | ![]() |
![]() |
|||
PO-1832 | Assessment of set up accuracy using an evacuated cushion for Proton Beam Therapy | David Roberts | ![]() |
![]() |
|||
PO-1833 | What is the best modality to distract patients during prolonged breath-holds? | Nicolas Audag | ![]() |
![]() |
|||
PO-1834 | INITIAL EVALUATION OF A NEW IMMOBILIZATION SYSTEM FOR LUNG SBRT | Manuel Fernandez Montes | ![]() |
![]() |
|||
PO-1835 | Interventions demonstrate potential to promote patient comfort during radiotherapy. | Simon Goldsworthy | ![]() |
![]() |
|||
PO-1836 | Impact of bladder and rectum preparation on in vivo dosimetry for prostate cancer patients | Yawo Atsu Constantino FIAGAN | ![]() |
![]() |
|||
PO-1838 | Multiple Brain Mets: impact of patient positioning errors on optimal PTV margin strategy | Luca Capone | ![]() |
![]() |
|||
PO-1839 | Implementation of image reduction for DIBH/FB breast patients following evaluation of an SGRT device | Michael Heinitz | ![]() |
![]() |
|||
PO-1840 | Introduction of a Pre-Radiotherapy Hydration Consultation for prostate patients | Wendy Goldshaker | ![]() |
![]() |
|||
PO-1841 | Efficacy of a new dedicated immobilization device for treatment of Central Nervous disease | niccolo giaj levra | ![]() |
![]() |
|||
PO-1842 | Set-up accuracy of BrainLab immobilization mask for intracranial stereotactic radiotherapy | Clelia Di Carlo | ![]() |
![]() |
|||
PO-1843 | Bladder and rectum volume control at the CT simulation stage of curative pelvic patients protocol | Martin Berg | ![]() |
![]() |
|||
PO-1844 | Service evaluation of a new bladder filling protocol for radical prostate radiotherapy | Donna Burns | ![]() |
![]() |
|||
PO-1845 | Time trend analysis of target volume auto-contouring in locally advanced NSCLC over the course of RT | Sarah Barrett | ![]() |
![]() |
|||
PO-1846 | Inter-faction reproducibility of organs at risk in prostate and rectum RT treatments. | Nuria Espinosa | ![]() |
![]() |
|||
PO-1847 | ART in prostate cancer: how to use an offline approach with daily CBCT and deformable registration | Luca Capone | ![]() |
![]() |
|||
PO-1848 | Non-invasive Cardiac Radioablation for Ventricular Tachycardia | Karen Pilling | ![]() |
![]() |
|||
PO-1849 | Evaluation of an automatic contouring software in breast cancer treated in lateral position | Rebecca Msika | ![]() |
![]() |
|||
PO-1850 | Inter-observer variation in delineating cardiac substructures and coronary arteries | Zeineb Naimi | ![]() |
![]() |
|||
PO-1851 | Stereotactic radiation therapy for lung cancer: is a single 4-dimensional scan enough? | Ana Gonzalez Moya | ![]() |
![]() |
|||
PO-1852 | Changes in Dose Distribution in VMAT Plan for T3/4 NPC cases after teeth removal | Yim Li | ![]() |
![]() |
|||
PO-1854 | The effect of SpaceOAR hydrogel and posteriorly misplaced treatment on rectum dose in prostate SBRT | Antti Vanhanen | ![]() |
![]() |
|||
PO-1855 | Dosimetric effects of online adaptive replanning for prostate radiation therapy on 1.5T MR-Linac | Man Chun Lee | ![]() |
![]() |
|||
PO-1856 | VMAT class solution for radiotherapy planning of esophageal carcinoma using Pinnacle Auto-Plan | Leontien Abbenhuis | ![]() |
![]() |
|||
PO-1857 | A robust two isocenter VMAT technique for bilateral breast cancer. | Peter Van Kollenburg | ![]() |
![]() |
|||
PO-1858 | Quality assurance of proton treatment plans by evaluating uncertainty doses in brain tumors. | Ihsan Bahij | ![]() |
![]() |
|||
PO-1859 | Evaluation of atlas-based synthetic CT for MRI radiotherapy planning in the head and neck region | Patricia Man Hei Lee | ![]() |
![]() |
|||
PO-1860 | Organs-at-risk sparing capabilities of Hybrid Partial-field VMAT during Whole Brain Radiotherapy | Adams Hei Long Yuen | ![]() |
![]() |
|||
PO-1861 | Impact of setup error in postoperative breast/chest wall radiotherapy with field in field technique | Makita Kenji | ![]() |
![]() |
|||
PO-1864 | Can underdosage due to breast swelling be mitigated with robust optimization for breast radiotherapy | Koen Crama | ![]() |
![]() |
|||
PO-1865 | Quality control of SBRT treatments with VMAT | Manuel Fernandez Montes | ![]() |
![]() |
|||
PO-1866 | Comparison of dose evaluation using difference voxel sizes in Stereotactic Radiotherapy Planning | Tin Lok Lai | ![]() |
![]() |
|||
PO-1868 | In silico hypofractionation feasibility study for lymph node oligometastases SBRT on the MRI-linac | Dennis Winkel | ![]() |
![]() |
|||
PO-1869 | Dosimetry impact of manual vs. automated segmentation of lung contours in RayStation (RS) | Fabiol Vallejo Castañeda | ![]() |
![]() |
|||
PO-1870 | Distal esophageal cancer - should we use 3D-CRT, IMRT or VMAT? | Turid Husevg Sulen | ![]() |
![]() |
|||
PO-1872 | Dosimetric comparison of VMAT vs t-IMRT for patients with Aeroform Air Expanders undergoing PMRT | Margaret Cokelek | ![]() |
![]() |
|||
PO-1873 | SIDCA in patients with = 10 brain mets: evaluation of neurological toxicity and treatment accuracy. | Luca Capone | ![]() |
![]() |
|||
PO-1874 | Improving Treatment Accuracy of Cranial Boost Radiotherapy (RT) with Total Body Irradiation (TBI) | Ian Zing Tan | ![]() |
![]() |
|||
PO-1875 | Is a single anterior field sufficient to treat regional nodes in breast cancer? | Hanan Almasri | ![]() |
![]() |
|||
PO-1876 | A visual grading analysis-based audit for MR simulation sequence development | Lisa McDaid | ![]() |
![]() |
|||
PO-1877 | Dosimetric parameters associated with overall survival and toxicity in stage III NSCLC patients | Isabel Remmerts de Vries | ![]() |
![]() |
|||
PO-1879 | A novel and objective plan evaluation tool for dose escalation in NSCLC within the ADCSCaN trial | Rita Simoes | ![]() |
![]() |
|||
PO-1880 | Cardiac exposure in left-sided breast cancer radiotherapy: which substructure should be contoured? | Zeineb Naimi | ![]() |
![]() |
|||
PO-1881 | Dosimetric impact of left anterior descending artery contouring in left-sided breast irradiation | Zeineb Naimi | ![]() |
![]() |
|||
PO-1882 | The risk of pelvic insufficiency fractures after radiotherapy using planned dose analysis. | Lynsey Devlin | ![]() |
![]() |
|||
PO-1883 | Movement of the hyoid during head and neck radiotherapy: Implications for off-line verification | Sarah Hargreaves | ![]() |
![]() |
|||
PO-1884 | Matching time optimization in tangential breast RTT: CBCT and EPI comparison | Andrea Lastrucci | ![]() |
![]() |
|||
PO-1885 | Margin evaluation and Plan-of-the-day exploration for rectal tumors | Esther Kneepkens | ![]() |
![]() |
|||
PO-1886 | Dosimetric impact of groin oedema in inguinal lymph node boosts in locally advanced vulvar cancer | Sandy Mohamed Ismail Mohamed | ![]() |
![]() |
|||
PO-1888 | Dose effects of interfraction target shifts in irradiation of prostate with two partial VMAT arcs. | Marjan Admiraal | ![]() |
![]() |
|||
PO-1889 | To evaluate the feasibility of MR-only pelvis TomoTherapy during treatment planning and verification | Shei Yee Man | ![]() |
![]() |
|||
PO-1890 | Comparative assessment of the verification performance, ART and imaging dose between MVCT and kVCBCT | Phoebe YS Tang | ![]() |
![]() |
|||
PO-1891 | Bladder filling assessment in prostate cancer patients using ultrasound bladder measurements | Krzysztof Kaczmarek | ![]() |
![]() |
|||
PO-1892 | Stereotactic Radiation Therapy how accurate we are? | Jelizaveta Ter-MInasjan | ![]() |
![]() |
|||
PO-1893 | Average body diameter as a predictive factor for the usability of inline CBCT for spine SBRT | Jikke Stam | ![]() |
![]() |
|||
PO-1894 | AD-HOC ADAPTIVE RADIOTHERAPY: HOW OFTEN DO ANATOMICAL CHANGES LEAD TO TREATMENT ADAPTATION? | Yvonne van Herten | ![]() |
![]() |
|||
PO-1896 | Implant geometry based PTV margins for prostate patients with daily setup on markers | virginia Spies | ![]() |
![]() |
|||
PO-1900 | Is the 4D planning CT representative for breathing motion of esophageal tumors during treatment? | Quirine Roos | ![]() |
![]() |
|||
PO-1902 | Cone Beam Computed Tomography to assess pitch, roll and rotation in Head and Neck Radiotherapy | Debbie Thornberry | ![]() |
![]() |
|||
PO-1903 | Inter-observer variability of CTV registration in image-guided radiotherapy of oesophageal cancer. | Lisa Wiersema | ![]() |
![]() |
|||
PO-1904 | ROI optimization for surface guided radiation therapy | Tim-Oliver Sauer | ![]() |
![]() |
|||
PO-1905 | IGRT protocols analysis in brain radiotherapy treatment | Andrea Lastrucci | ![]() |
![]() |
|||
PO-1907 | The effectiveness of SGRT for patient set-up in thoracic deep target radiotherapy | Stefano Leva | ![]() |
![]() |
|||
PO-1908 | Comparing soft tissue and bone to verify radiotherapy treatment position for lung cancer patients | Alison Sweeney | ![]() |
![]() |
|||
PO-1909 | Interobserver variability of CBCT for prostate radiation therapy: Fiducial Markers vs CTV/PTV | Fatima Aurora Aires | ![]() |
![]() |
|||
PO-1911 | Comparison of in-house self-held respiratory monitoring device and Active Breathing Coordinator system in deep inspiration breath-hold left breast radiotherapy | Wai Kit Chow | ![]() |
![]() |
|||
PO-1912 | Clinical experience of using stereotactic ablative body radiotherapy on inoperable pancreatic cancer | Yat Tsang | ![]() |
![]() |
|||
PO-1914 | Patient compliance during Deep Inspiration Breath Hold for left breast cancer radiotherapy | Marta Marson | ![]() |
![]() |
|||
PO-1915 | DOSIMETRIC IMPACT OF NON-COMPLIANCE/VCD FAILURE IN LEFT BREAST RT TREATMENTS IN DIBH | Guillermo Gomez de Segura | ![]() |
![]() |
|||
PO-1916 | Applications of the Medusa surface tracking system for respiratory control in breast cancer patients | Emilie Costa | ![]() |
![]() |
|||
PO-1917 | Pre-trial plan ion training - is it sufficient for optimal plan ions online? | Amanda Webster | ![]() |
![]() |
|||
PO-1919 | DIBH reduces right coronary artery and lung radiation dose in right breast cancer loco-regional RT | Kirsty Stuart | ![]() |
![]() |
|||
PO-1920 | Inter-fractional uterine and cervix motion during radiotherapy for cervix cancer | Gillian Bestwick Lewis | ![]() |
![]() |
|||
PO-1922 | Dosimetric replanification benefit in exceeded neurological structures doses during IMRT for NPC | Daoud Hend | ![]() |
![]() |
|||
PO-1924 | RADIOTHERAPY LATE EFFECTS: SEXUAL CARE AFTER RADIOTHERAPY - A RTT LED SEXUAL CARE CLINIC | Heather Nisbet | ![]() |
![]() |
|||
PO-1926 | Defining compassion in cancer care: a co-production approach | Amy Taylor | ![]() |
![]() |
|||
PO-1927 | Palliative haemostatic radiotherapy in gastro-oesophageal cancer- a single centre experience | Karen Crowther | ![]() |
![]() |
|||
PO-1928 | Initial clinical experience with the MR-Linac System - Patient perspective | Nienke Weitkamp | ![]() |
![]() |
|||
PO-1929 | Correlation between dosimetric parameters and acute dermatitis of hypofractionated breast radiation | Meriem Bohli | ![]() |
![]() |
|||
PO-1931 | To evaluate the effectiveness of hydroactive colloid gel in the skincare pathway for patients having breast radiotherapy. | Joanne Rigley | ![]() |
![]() |
|||
PO-1932 | Patients-Reported Outcomes (PROs) following SBRT for clinically localized Prostate Cancer | Aleksandra Ma&324;czak | ![]() |
![]() |
|||
PO-1933 | Radiation therapists practices, barriers and facilitators in delivering health behaviour advice. | Nickola Pallin | ![]() |
![]() |
|||
PO-1934 | Multidisciplinary training using a virtual environment in radiotherapy | Angela Williams | ![]() |
![]() |
|||
PO-1935 | MR-only prostate radiotherapy how transferable are CT based image matching skills? | Rachel Brooks | ![]() |
![]() |
|||
PO-1936 | Establishing the acceptability of a gold standard in IGRT assessment for Radiation Therapists | Elinor Barker | ![]() |
![]() |
|||
PO-1937 | A new software for advanced education and assessment of tumour volume delineation in radiotherapy | Concetta Piazzese | ![]() |
![]() |
|||
PO-1938 | Implementation of Stereotactic Radiosurgery (SRS) for brain metastases. | Anja Nielsen | ![]() |
![]() |
|||
PO-1939 | Training of RTT on CBCT online adaptive radiotherapy: First step finding the future adapters | Lina Andersson | ![]() |
![]() |
|||
PO-1941 | Current perspectives of RTTs in radiation oncology research: a national survey in Italy | Domenico Piro | ![]() |
![]() |
|||
PO-1942 | Palliative Radiotherapy Peer Review; A Multi-disciplinary retrospective audit. | joanne mitchell | ![]() |
![]() |
|||
PO-1943 | Analysis of RT performance using quality indicators derived from automated treatment pathways | Luca Capone | ![]() |
![]() |
|||
PO-1944 | FMECA analysis of VMAT prostate treatment | Andrea Lastrucci | ![]() |
![]() |
|||
PO-1945 | Practical test of proton plan before first treatment | Pernille Haslund | ![]() |
![]() |
|||
PO-1946 | Risk management for intraoperative electron radiotherapy accelerators | Agnieszka Misiarz | ![]() |
![]() |
28 November - 01 December 2020 Virtual
![]() |
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|